
<!DOCTYPE html>
<html lang="en" >
    <head >

        <meta charset="UTF-8" />
        <meta http-equiv="X-UA-Compatible" content="IE=edge" />
        <meta name="HandheldFriendly" content="True" />
        <meta name="MobileOptimized" content="320" />
        <meta name="viewport" content="width=device-width, initial-scale=1.0" />

        
        

        
        
  <link rel="stylesheet" href="/static/assets/base_style-CPPDhfna.css" />
<script type="module" crossorigin="" src="/static/assets/base_style-BepKMsUl.js"></script>

  <link rel="stylesheet" href="/static/assets/article_style-DUfI1jZp.css" />
<link rel="stylesheet" href="/static/assets/style-BOrsu84o.css" />
<script type="module" crossorigin="" src="/static/assets/article_style-D3wJHomh.js"></script>

  
  
    <style>
  
  
  @media screen and (min-width: 64em) {
    div.pmc-wm {
      background: repeat-y;
      background-image: url("data:image/svg+xml,%3Csvg xmlns='http://www.w3.org/2000/svg' width='20' height='350' xmlns:xlink='http://www.w3.org/1999/xlink'%3E%3Cdefs%3E%3Cfilter x='-.02' y='0' width='1.05' height='1' id='c'%3E%3CfeFlood flood-color='%23FFF'/%3E%3CfeComposite in='SourceGraphic'/%3E%3C/filter%3E%3Ctext id='b' font-family='Helvetica' font-size='11pt' style='opacity:1;fill:%23005ea2;stroke:none;text-anchor:middle' x='175' y='14'%3E%3C/text%3E%3Cpath id='a' style='fill:%23005ea2' d='M0 8h350v3H0z'/%3E%3C/defs%3E%3Cuse xlink:href='%23a' transform='rotate(90 10 10)'/%3E%3Cuse xlink:href='%23b' transform='rotate(90 10 10)' filter='url(%23c)'/%3E%3C/svg%3E");
      padding-left: 3rem;
    }
  }
</style>

  



        
            <link rel="apple-touch-icon"
                  sizes="180x180"
                  href="/static/img/favicons/apple-touch-icon.png" />
            <link rel="icon"
                  type="image/png"
                  sizes="48x48"
                  href="/static/img/favicons/favicon-48x48.png" />
            <link rel="icon"
                  type="image/png"
                  sizes="32x32"
                  href="/static/img/favicons/favicon-32x32.png" />
            <link rel="icon"
                  type="image/png"
                  sizes="16x16"
                  href="/static/img/favicons/favicon-16x16.png" />
            <link rel="manifest" href="/static/img/favicons/site.webmanifest" />
            <link rel="mask-icon"
                  href="/static/img/favicons/safari-pinned-tab.svg"
                  color="#0071bc" />
            <meta name="msapplication-config"
                  content="/static/img/favicons/browserconfig.xml" />
            <meta name="theme-color" content="#ffffff" />
        

        <title>
            Randomized Phase Ib Clinical Trial of DB-020 Intratympanic Injections to Reduce High-Dose Cisplatin Ototoxicity - PMC
        </title>

        
        
  
  <!-- Logging params: Pinger defaults -->
<meta name="ncbi_app" content="cloudpmc-viewer" />
<meta name="ncbi_db" content="pmc" />
<meta name="ncbi_phid" content="18DE24BD930AFC630024BD00445F433A.m_1" />
<meta name="ncbi_pinger_stat_url" content="https://pmc.ncbi.nlm.nih.gov/stat" />
<!-- Logging params: Pinger custom -->
<meta name="ncbi_pdid" content="article" />
  
    <link rel="preconnect" href="https://www.google-analytics.com" />

    
        <link rel="preconnect" href="https://cdn.ncbi.nlm.nih.gov" />
    

    <!-- Include USWDS Init Script -->
    <script src="/static/assets/uswds-init.js"></script>


    <meta name="ncbi_domain" content="lwwopen">
<meta name="ncbi_type" content="fulltext">
<meta name="ncbi_pcid" content="journal">
<meta name="ncbi_feature" content="associated_data">
<link rel="canonical" href="https://pmc.ncbi.nlm.nih.gov/articles/PMC12199801/">
<meta name="robots" content="INDEX,NOFOLLOW,NOARCHIVE">
<meta name="citation_journal_title" content="Journal of Clinical Oncology">
<meta name="citation_title" content="Randomized Phase Ib Clinical Trial of DB-020 Intratympanic Injections to Reduce High-Dose Cisplatin Ototoxicity">
<meta name="citation_author" content="Benedict J Panizza">
<meta name="citation_author_institution" content="Princess Alexandra Hospital, Brisbane, Australia">
<meta name="citation_author_institution" content="University of Queensland, Brisbane, Australia">
<meta name="citation_author" content="Stephen John O&#x27;Leary">
<meta name="citation_author_institution" content="The University of Melbourne, Melbourne, Australia">
<meta name="citation_author" content="Christopher David Hart">
<meta name="citation_author_institution" content="St Vincent&#x27;s Hospital Melbourne, Melbourne, Australia">
<meta name="citation_author" content="Chandra Sai Diwakarla">
<meta name="citation_author_institution" content="Fiona Stanley Hospital, Perth, Australia">
<meta name="citation_author" content="Catherine Barnett">
<meta name="citation_author_institution" content="Princess Alexandra Hospital, Brisbane, Australia">
<meta name="citation_author" content="Pablo Lapuerta">
<meta name="citation_author_institution" content="Lapuerta Consulting LLC, Skillman, NJ">
<meta name="citation_author" content="John Lee">
<meta name="citation_author_institution" content="Decibel Therapeutics Inc, Boston, MA">
<meta name="citation_author" content="Shane Raines">
<meta name="citation_author_institution" content="Decibel Therapeutics Inc, Boston, MA">
<meta name="citation_author" content="Tera Quigley">
<meta name="citation_author_institution" content="Decibel Therapeutics Inc, Boston, MA">
<meta name="citation_author" content="Heather M Wolff">
<meta name="citation_author_institution" content="Decibel Therapeutics Inc, Boston, MA">
<meta name="citation_author" content="John Keilty">
<meta name="citation_author_institution" content="Decibel Therapeutics Inc, Boston, MA">
<meta name="citation_author" content="Rahul Ladwa">
<meta name="citation_author_institution" content="Princess Alexandra Hospital, Brisbane, Australia">
<meta name="citation_author_institution" content="University of Queensland, Brisbane, Australia">
<meta name="citation_author" content="Sandro V Porceddu">
<meta name="citation_author_institution" content="Peter MacCallum Cancer Centre, Melbourne, Australia">
<meta name="citation_author" content="Margaret McGrath">
<meta name="citation_author_institution" content="Princess Alexandra Hospital, Brisbane, Australia">
<meta name="citation_author" content="Nagashree Seetharamu">
<meta name="citation_author_institution" content="Northwell Health, New Hyde Park, NY">
<meta name="citation_author" content="Tsien Fua">
<meta name="citation_author_institution" content="University of Queensland, Brisbane, Australia">
<meta name="citation_author" content="Danny Rischin">
<meta name="citation_author_institution" content="The University of Melbourne, Melbourne, Australia">
<meta name="citation_author_institution" content="Peter MacCallum Cancer Centre, Melbourne, Australia">
<meta name="citation_publication_date" content="2025 May 22">
<meta name="citation_volume" content="43">
<meta name="citation_issue" content="19">
<meta name="citation_firstpage" content="2155">
<meta name="citation_doi" content="10.1200/JCO.24.00905">
<meta name="citation_pmid" content="40403227">
<meta name="citation_abstract_html_url" content="https://pmc.ncbi.nlm.nih.gov/articles/PMC12199801/">
<meta name="citation_fulltext_html_url" content="https://pmc.ncbi.nlm.nih.gov/articles/PMC12199801/">
<meta name="citation_pdf_url" content="https://pmc.ncbi.nlm.nih.gov/articles/PMC12199801/pdf/jco-43-2155.pdf">
<meta name="description" content="This study evaluated DB-020, a formulation of thiosulfate for intratympanic (IT) injection, in patients receiving high-dose cisplatin chemotherapy. This randomized phase Ib clinical trial enrolled patients older than 18 years from five centers in ...">
<meta name="og:title" content="Randomized Phase Ib Clinical Trial of DB-020 Intratympanic Injections to Reduce High-Dose Cisplatin Ototoxicity">
<meta name="og:type" content="article">
<meta name="og:site_name" content="PubMed Central (PMC)">
<meta name="og:description" content="This study evaluated DB-020, a formulation of thiosulfate for intratympanic (IT) injection, in patients receiving high-dose cisplatin chemotherapy. This randomized phase Ib clinical trial enrolled patients older than 18 years from five centers in ...">
<meta name="og:url" content="https://pmc.ncbi.nlm.nih.gov/articles/PMC12199801/">
<meta name="og:image" content="https://cdn.ncbi.nlm.nih.gov/pmc/cms/images/pmc-card-share.jpg?_=0">
<meta name="twitter:card" content="summary_large_image">
<meta name="twitter:site" content="@ncbi">
    
    

    </head>
    <body >
        
    <a class="usa-skipnav " href="#main-content">
      Skip to main content
    </a>


        
            

<section class="usa-banner " aria-label="Official website of the United States government" >
    <div class="usa-accordion">
        <header class="usa-banner__header">
            <div class="usa-banner__inner">
                <div class="grid-col-auto">
                    <img aria-hidden="true"
                         class="usa-banner__header-flag"
                         src="/static/img/us_flag.svg"
                         alt="" />
                </div>

                <div class="grid-col-fill tablet:grid-col-auto" aria-hidden="true">
                    <p class="usa-banner__header-text">
                        An official website of the United States government
                    </p>
                    <span class="usa-banner__header-action">Here's how you know</span>
                </div>

                



















    
        <button
            type="button"
        
    
    class="usa-accordion__button usa-banner__button
           

           
               
               
               
               
            

           
           
           
           "
    aria-expanded="false"
    aria-controls="gov-banner-default"
    
    data-testid="storybook-django-banner"
    
    >
    
        

        
                    <span class="usa-banner__button-text">Here's how you know</span>
                

        
    
        
            </button>
        


            </div>
        </header>

        <div class="usa-banner__content usa-accordion__content"
             id="gov-banner-default"
             hidden>
            <div class="grid-row grid-gap-lg">
                <div class="usa-banner__guidance tablet:grid-col-6">
                    <img class="usa-banner__icon usa-media-block__img"
                         src="/static/img/icon-dot-gov.svg"
                         alt=""
                         aria-hidden="true" />
                    <div class="usa-media-block__body">
                        <p>
                            <strong>Official websites use .gov</strong>
                            <br />
                            A
                            <strong>.gov</strong> website belongs to an official
                            government organization in the United States.
                        </p>
                    </div>
                </div>

                <div class="usa-banner__guidance tablet:grid-col-6">
                    <img class="usa-banner__icon usa-media-block__img"
                         src="/static/img/icon-https.svg"
                         alt=""
                         aria-hidden="true" />

                    <div class="usa-media-block__body">
                        <p>
                            <strong>Secure .gov websites use HTTPS</strong>
                            <br />
                            A <strong>lock</strong> (
                            <span class="icon-lock">
                                <svg xmlns="http://www.w3.org/2000/svg"
                                     width="52"
                                     height="64"
                                     viewBox="0 0 52 64"
                                     class="usa-banner__lock-image"
                                     role="graphics-symbol"
                                     aria-labelledby="banner-lock-description"
                                     focusable="false">
                                    <title id="banner-lock-title">Lock</title>
                                    <desc id="banner-lock-description">
                                    Locked padlock icon
                                    </desc>
                                    <path fill="#000000"
                                          fill-rule="evenodd"
                                          d="M26 0c10.493 0 19 8.507 19 19v9h3a4 4 0 0 1 4 4v28a4 4 0 0 1-4 4H4a4 4 0 0 1-4-4V32a4 4 0 0 1 4-4h3v-9C7 8.507 15.507 0 26 0zm0 8c-5.979 0-10.843 4.77-10.996 10.712L15 19v9h22v-9c0-6.075-4.925-11-11-11z" />
                                </svg>
</span>) or <strong>https://</strong> means you've safely
                                connected to the .gov website. Share sensitive
                                information only on official, secure websites.
                            </p>
                        </div>
                    </div>
                </div>
            </div>
        </div>
    </section>

        

        
    
    
    

<div class="usa-overlay">
</div>



<header class="usa-header usa-header--extended usa-header--wide" data-header data-testid="header"    >
    <div class="ncbi-header">
        <div class="ncbi-header__container">
            <a class="ncbi-header__logo-container"
               href="https://www.ncbi.nlm.nih.gov/">
                <img alt="NCBI home page"
                     class="ncbi-header__logo-image"
                     src="/static/img/ncbi-logos/nih-nlm-ncbi--white.svg"
                     width="410"
                     height="100" />
            </a>

            <!-- Mobile menu hamburger button -->
            



















    
        <button
            type="button"
        
    
    class="usa-menu-btn ncbi-header__hamburger-button
           

           
               
               
               
               
            

           
           
           
           "
    
    
    aria-label="Show menu"
    data-testid="navMenuButton"
    
    >
    
        

        
                <svg aria-hidden="true"
                     class="ncbi-hamburger-icon"
                     fill="none"
                     focusable="false"
                     height="21"
                     viewBox="0 0 31 21"
                     width="31"
                     xmlns="http://www.w3.org/2000/svg">
                    <path clip-rule="evenodd"
                          d="M0.125 20.75H30.875V17.3333H0.125V20.75ZM0.125 12.2083H30.875V8.79167H0.125V12.2083ZM0.125 0.25V3.66667H30.875V0.25H0.125Z"
                          fill="#F1F1F1"
                          fill-rule="evenodd" />
                </svg>
            

        
    
        
            </button>
        



            
                <!-- Desktop buttons-->
                <div class="ncbi-header__desktop-buttons">
                    
                        <!-- Desktop search button -->
                        



















    
        <button
            type="button"
        
    
    class="usa-button
           

           
               
               
               
               
            

           
           
           usa-button--unstyled ncbi-header__desktop-button
           "
    aria-expanded="false"
    aria-controls="search-field-desktop-navigation"
    aria-label="Show search overlay"
    data-testid="toggleSearchPanelButton"
    data-toggle-search-panel-button
    >
    
        

        
                            



    <svg class="usa-icon " role="graphics-symbol" aria-hidden="true" >
        
        <use xlink:href="/static/img/sprite.svg#search" />
    </svg>


                            Search
                        

        
    
        
            </button>
        


                    

                    <!-- Desktop login dropdown -->
                    
                        <div class="ncbi-header__login-dropdown">
                            



















    
        <button
            type="button"
        
    
    class="usa-button
           

           
               
               
               
               
            

           
           
           usa-button--unstyled ncbi-header__desktop-button ncbi-header__login-dropdown-button
           "
    aria-expanded="false"
    aria-controls="login-dropdown-menu"
    aria-label="Show login menu"
    data-testid="toggleLoginMenuDropdown"
    data-desktop-login-button
    >
    
        

        
                                



    <svg class="usa-icon " role="graphics-symbol" aria-hidden="true" >
        
        <use xlink:href="/static/img/sprite.svg#person" />
    </svg>



                                <span data-login-dropdown-text>Log in</span>

                                <!-- Dropdown icon pointing up -->
                                



    <svg class="usa-icon ncbi-header__login-dropdown-icon ncbi-header__login-dropdown-icon--expand-less ncbi-header__login-dropdown-icon--hidden" role="graphics-symbol" aria-hidden="true" data-login-dropdown-up-arrow>
        
        <use xlink:href="/static/img/sprite.svg#expand_less" />
    </svg>



                                <!-- Dropdown icon pointing down -->
                                



    <svg class="usa-icon ncbi-header__login-dropdown-icon ncbi-header__login-dropdown-icon--expand-more ncbi-header__login-dropdown-icon--hidden" role="graphics-symbol" aria-hidden="true" data-login-dropdown-down-arrow>
        
        <use xlink:href="/static/img/sprite.svg#expand_more" />
    </svg>


                            

        
    
        
            </button>
        



                            <!-- Login dropdown menu -->
                            <ul class="usa-nav__submenu ncbi-header__login-dropdown-menu"
                                id="login-dropdown-menu"
                                data-desktop-login-menu-dropdown
                                hidden>
                                
                                    <li class="usa-nav__submenu-item">
                                        <!-- Uses custom style overrides to render external and document links. -->
                                        









    <a href="https://www.ncbi.nlm.nih.gov/myncbi/" class="usa-link  "  >
        

        
            Dashboard
        

        
    </a>


                                    </li>
                                
                                    <li class="usa-nav__submenu-item">
                                        <!-- Uses custom style overrides to render external and document links. -->
                                        









    <a href="https://www.ncbi.nlm.nih.gov/myncbi/collections/bibliography/" class="usa-link  "  >
        

        
            Publications
        

        
    </a>


                                    </li>
                                
                                    <li class="usa-nav__submenu-item">
                                        <!-- Uses custom style overrides to render external and document links. -->
                                        









    <a href="https://www.ncbi.nlm.nih.gov/account/settings/" class="usa-link  "  >
        

        
            Account settings
        

        
    </a>


                                    </li>
                                
                                <li class="usa-nav__submenu-item">
                                    



















    
        <button
            type="button"
        
    
    class="usa-button
           

           
               
               
               
               
            

           
           
           usa-button--outline ncbi-header__login-dropdown-logout-button
           "
    
    
    
    data-testid="desktopLogoutButton"
    data-desktop-logout-button
    >
    
        

        Log out

        
    
        
            </button>
        


                                </li>
                            </ul>
                        </div>
                    
                </div>
            
        </div>
    </div>

    <!-- Search panel -->
    
        <div class="ncbi-search-panel ncbi--show-only-at-desktop"
             data-header-search-panel
             hidden>
            <div class="ncbi-search-panel__container">
                <form action="https://www.ncbi.nlm.nih.gov/search/all/"
                      
                      autocomplete="off"
                      class="usa-search usa-search--big ncbi-search-panel__form"
                      data-testid="desktop-navigation-search-form"
                      method="GET"
                      role="search">
                    <label class="usa-sr-only" for="search-field-desktop-navigation">
                        Search…
                    </label>
                    <input class="usa-input"
                           id="search-field-desktop-navigation"
                           name="term"
                           
                               placeholder="Search NCBI"
                           
                           type="search"
                           value="" />
                    



















    
        <button
            type="submit"
        
    
    class="usa-button
           

           
               
               
               
               
            

           
           
           
           "
    
    
    
    
    
    >
    
        

        
                        <span class="usa-search__submit-text">
                            Search NCBI
                        </span>
                    

        
    
        
            </button>
        


                </form>

                
            </div>
        </div>
    

    <nav aria-label="Primary navigation" class="usa-nav">
        <p class="usa-sr-only" id="primary-navigation-sr-only-title">
            Primary site navigation
        </p>

        <!-- Mobile menu close button -->
        



















    
        <button
            type="button"
        
    
    class="usa-nav__close ncbi-nav__close-button
           

           
               
               
               
               
            

           
           
           
           "
    
    
    aria-label="Close navigation menu"
    data-testid="navCloseButton"
    
    >
    
        

        
            <img src="/static/img/usa-icons/close.svg" alt="Close" />
        

        
    
        
            </button>
        



        
            <!-- Mobile search component -->
            <form class="usa-search usa-search--small ncbi--hide-at-desktop margin-top-6"
                  action="https://www.ncbi.nlm.nih.gov/search/all/"
                  
                  autocomplete="off"
                  data-testid="mobile-navigation-search-form"
                  method="GET"
                  role="search">
                <label class="usa-sr-only" for="search-field-mobile-navigation">
                    Search
                </label>

                <input class="usa-input"
                       id="search-field-mobile-navigation"
                       type="search"
                       
                           placeholder="Search NCBI"
                       
                       name="term" />

                



















    
        <button
            type="submit"
        
    
    class="usa-button
           

           
               
               
               
               
            

           
           
           
           "
    
    
    
    
    
    >
    
        

        
                    <!-- This SVG should be kept inline and not replaced with a link to the icon as otherwise it will render in the wrong color -->
                    <img src="data:image/svg+xml;base64,PHN2ZyB4bWxucz0iaHR0cDovL3d3dy53My5vcmcvMjAwMC9zdmciIGhlaWdodD0iMjQiIHZpZXdCb3g9IjAgMCAyNCAyNCIgd2lkdGg9IjI0Ij48cGF0aCBkPSJNMCAwaDI0djI0SDB6IiBmaWxsPSJub25lIi8+PHBhdGggZmlsbD0iI2ZmZiIgZD0iTTE1LjUgMTRoLS43OWwtLjI4LS4yN0E2LjQ3MSA2LjQ3MSAwIDAgMCAxNiA5LjUgNi41IDYuNSAwIDEgMCA5LjUgMTZjMS42MSAwIDMuMDktLjU5IDQuMjMtMS41N2wuMjcuMjh2Ljc5bDUgNC45OUwyMC40OSAxOWwtNC45OS01em0tNiAwQzcuMDEgMTQgNSAxMS45OSA1IDkuNVM3LjAxIDUgOS41IDUgMTQgNy4wMSAxNCA5LjUgMTEuOTkgMTQgOS41IDE0eiIvPjwvc3ZnPg=="
                         class="usa-search__submit-icon"
                         alt="Search" />
                

        
    
        
            </button>
        


            </form>

            
        

        <!-- Primary navigation menu items -->
        <!-- This usa-nav__inner wrapper is required to correctly style the navigation items on Desktop -->
        

        
            <div class="ncbi-nav__mobile-login-menu ncbi--hide-at-desktop"
                 data-mobile-login-menu
                 hidden>
                <p class="ncbi-nav__mobile-login-menu-status">
                    Logged in as:
                    <strong class="ncbi-nav__mobile-login-menu-email"
                            data-mobile-login-email-text></strong>
                </p>
                <ul class="usa-nav__primary usa-accordion">
                    
                        <li class="usa-nav__primary-item">
                            









    <a href="https://www.ncbi.nlm.nih.gov/myncbi/" class="usa-link  "  >
        

        
            Dashboard
        

        
    </a>


                        </li>
                    
                        <li class="usa-nav__primary-item">
                            









    <a href="https://www.ncbi.nlm.nih.gov/myncbi/collections/bibliography/" class="usa-link  "  >
        

        
            Publications
        

        
    </a>


                        </li>
                    
                        <li class="usa-nav__primary-item">
                            









    <a href="https://www.ncbi.nlm.nih.gov/account/settings/" class="usa-link  "  >
        

        
            Account settings
        

        
    </a>


                        </li>
                    
                </ul>
            </div>
        

        



















    
        <button
            type="button"
        
    
    class="usa-button
           

           
               
               
               
               
            

           
           
           ncbi-nav__mobile-login-button ncbi--hide-at-desktop
           "
    
    
    
    data-testid="mobileLoginButton"
    data-mobile-login-button
    >
    
        

        Log in

        
    
        
            </button>
        


    </nav>
</header>

    
    
        

<section class="pmc-header pmc-header--basic" aria-label="PMC Header with search box">
    <div class="pmc-nav-container">
        <div class="pmc-header__bar">
           <div class="pmc-header__logo">
               <a href="/" title="Home" aria-label="PMC Home"></a>
           </div>
            <button
                    type="button"
                    class="usa-button usa-button--unstyled pmc-header__search__button"
                    aria-label="Open search"
                    data-ga-category="search"
                    data-ga-action="PMC"
                    data-ga-label="pmc_search_panel_mobile"
            >
                <svg class="usa-icon width-4 height-4 pmc-icon__open" aria-hidden="true" focusable="false" role="img">
                    <use xlink:href="/static/img/sprite.svg#search"></use>
                </svg>
                <svg class="usa-icon width-4 height-4 pmc-icon__close" aria-hidden="true" focusable="false" role="img">
                    <use xlink:href="/static/img/sprite.svg#close"></use>
                </svg>
            </button>
        </div>
        <div class="pmc-header__search">
            


<form class="usa-search usa-search--extra usa-search--article-right-column  pmc-header__search__form" id="pmc-search-form" autocomplete="off" role="search">
<label class="usa-sr-only" for="pmc-search">Search PMC Full-Text Archive</label>
<span class="autoComplete_wrapper flex-1">
<input class="usa-input width-full maxw-none" required="required" placeholder="Search PMC Full-Text Archive" id="pmc-search"  type="search" name="term" data-autocomplete-url="https://pmc.ncbi.nlm.nih.gov/autocomp/search/autocomp/"/>
</span>
<button
class="usa-button"
type="submit"
formaction="https://pmc.ncbi.nlm.nih.gov/search/"
data-ga-category="search"
data-ga-action="PMC"
data-ga-label="PMC_search_button"
>
<span class="usa-search__submit-text">Search in PMC</span>
<img
src="/static/img/usa-icons-bg/search--white.svg"
class="usa-search__submit-icon"
alt="Search"
/>
</button>
</form>
            <div class="display-flex flex-column tablet:flex-row tablet:flex-justify flex-justify-center flex-align-center width-full desktop:maxw-44">
                <ul class="pmc-header__search__menu">
                    <li>
                        
                            <a class="usa-link" href="/journals/" data-ga-action="featured_link" data-ga-label="journal list">
                                Journal List
                            </a>
                        
                    </li>
                    <li>
                        
                            <a class="usa-link" href="/about/userguide/" data-ga-action="featured_link"
                            data-ga-label="user guide">
                                User Guide
                            </a>
                        
                    </li>
                </ul>
            </div>
        </div>
    </div>
</section>

    


        
        

       
  <div class="usa-section padding-top-0 desktop:padding-top-6 pmc-article-section" data-article-db="pmc" data-article-id="12199801">

    

   



<div class="grid-container pmc-actions-bar" aria-label="Actions bar" role="complementary">
    <div class="grid-row">
        <div class="grid-col-fill display-flex">
             <div class="display-flex">
                <ul class="usa-list usa-list--unstyled usa-list--horizontal">
                    <li class="margin-right-2 mobile-lg:margin-right-4 display-flex mob">
                        <button
                                type="button"
                                class="usa-button pmc-sidenav__container__open usa-button--unstyled width-auto display-flex"
                                aria-label="Open resources"
                                data-extra-class="is-visible-resources"
                                data-ga-category="resources_accordion"
                                data-ga-action="click"
                                data-ga-label="mobile_icon"
                        >
                            <svg class="usa-icon width-4 height-4" aria-hidden="true" focusable="false" role="img">
                                <use xlink:href="/static/img/sprite.svg#more_vert"></use>
                            </svg>
                        </button>
                    </li>
                    
                    <li class="margin-right-2 mobile-lg:margin-right-4 display-flex mob">
                        <a
                                href="https://doi.org/10.1200/JCO.24.00905"
                                class="usa-link display-flex usa-tooltip"
                                role="button"
                                target="_blank"
                                rel="noreferrer noopener"
                                title="View on publisher site"
                                data-position="bottom"
                                aria-label="View on publisher site"
                                data-ga-category="actions"
                                data-ga-action="click"
                                data-ga-label="publisher_link_mobile"
                        >
                                <svg class="usa-icon width-4 height-4" aria-hidden="true" focusable="false" role="img">
                                    <use xlink:href="/static/img/sprite.svg#launch"></use>
                                </svg>
                        </a>
                    </li>
                    
                    
                        <li class="margin-right-2 mobile-lg:margin-right-4 display-flex">
                             <a
                                     href="pdf/jco-43-2155.pdf"
                                     class="usa-link display-flex usa-tooltip"
                                     role="button"
                                     title="Download PDF"
                                     data-position="bottom"
                                     aria-label="Download PDF"
                                     data-ga-category="actions"
                                     data-ga-action="click"
                                     data-ga-label="pdf_download_mobile"
                             >
                                <svg class="usa-icon width-4 height-4" aria-hidden="true" focusable="false" role="img">
                                    <use xlink:href="/static/img/sprite.svg#file_download"></use>
                                </svg>
                            </a>
                        </li>
                    
                    <li class="margin-right-2 mobile-lg:margin-right-4 display-flex">
                        <button
                            class="usa-button usa-button--unstyled  usa-tooltip collections-dialog-trigger collections-button display-flex collections-button-empty"
                            title="Add to Collections"
                            data-position="bottom"
                            aria-label="Save article in MyNCBI collections."
                            data-ga-category="actions"
                            data-ga-action="click"
                            data-ga-label="collections_button_mobile"
                            data-collections-open-dialog-enabled="false"
                            data-collections-open-dialog-url="https://account.ncbi.nlm.nih.gov/?back_url=https%3A%2F%2Fpmc.ncbi.nlm.nih.gov%2Farticles%2FPMC12199801%2F%23open-collections-dialog"
                            data-in-collections="false"
                        >
                            <svg class="usa-icon width-4 height-4 usa-icon--bookmark-full" aria-hidden="true" focusable="false" role="img" hidden>
                                <use xlink:href="/static/img/action-bookmark-full.svg#icon"></use>
                            </svg>
                            <svg class="usa-icon width-4 height-4 usa-icon--bookmark-empty" aria-hidden="true" focusable="false" role="img" hidden>
                                <use xlink:href="/static/img/action-bookmark-empty.svg#icon"></use>
                            </svg>
                        </button>
                    </li>
                    
                    <li class="margin-right-2 mobile-lg:margin-right-4 display-flex">
                        <button role="button" class="usa-button usa-button--unstyled usa-tooltip citation-dialog-trigger display-flex"
                            aria-label="Open dialog with citation text in different styles"
                            title="Cite"
                            data-position="bottom"
                            data-ga-category="actions"
                            data-ga-action="open"
                            data-ga-label="cite_mobile"
                            data-all-citations-url="/resources/citations/12199801/"
                            data-citation-style="nlm"
                            data-download-format-link="/resources/citations/12199801/export/"
                        >
                            <svg class="usa-icon width-4 height-4 usa-icon--bookmark-empty" aria-hidden="true" focusable="false" role="img" hidden>
                                <use xlink:href="/static/img/sprite.svg#format_quote"></use>
                            </svg>
                        </button>
                    </li>
                    
                    <li class="pmc-permalink display-flex" >
                         <button
                                 type="button"
                                 title="Permalink"
                                 data-position="bottom"
                                 class="usa-button usa-button--unstyled display-flex usa-tooltip"
                                 aria-label="Show article permalink"
                                 aria-expanded="false"
                                 aria-haspopup="true"
                                 data-ga-category="actions"
                                 data-ga-action="open"
                                 data-ga-label="permalink_mobile"
                         >
                            <svg class="usa-icon width-4 height-4" aria-hidden="true" focusable="false" role="img">
                                <use xlink:href="/static/img/sprite.svg#share"></use>
                            </svg>
                        </button>
                        

<div class="pmc-permalink__dropdown" hidden>
    <div class="pmc-permalink__dropdown__container">
          <h2 class="usa-modal__heading margin-top-0 margin-bottom-2 text-uppercase font-sans-xs">PERMALINK</h2>
          <div class="pmc-permalink__dropdown__content">
              <input type="text" class="usa-input" value="https://pmc.ncbi.nlm.nih.gov/articles/PMC12199801/" aria-label="Article permalink">
              <button class="usa-button display-inline-flex pmc-permalink__dropdown__copy__btn margin-right-0" title="Copy article permalink" data-ga-category="save_share" data-ga-action="link" data-ga-label="copy_link">
                  <svg class="usa-icon" aria-hidden="true" focusable="false" role="img">
                    <use xlink:href="/static/img/sprite.svg#content_copy"></use>
                  </svg>
                  <span class="margin-left-1">Copy</span>
              </button>
          </div>
    </div>
</div>
                    </li>
                </ul>
            </div>
            <button
                    type="button"
                    class="usa-button pmc-sidenav__container__open usa-button--unstyled width-auto display-flex"
                    aria-label="Open article navigation"
                    data-extra-class="is-visible-in-page"
                    data-ga-category="actions"
                    data-ga-action="open"
                    data-ga-label="article_nav_mobile"
            >
                <svg class="usa-icon width-4 height-4" aria-hidden="true" focusable="false" role="img">
                    <use xlink:href="/static/img/sprite.svg#list"></use>
                </svg>
            </button>
        </div>
    </div>
</div>
    <div class="grid-container desktop:padding-left-6">
      <div id="article-container" class="grid-row grid-gap">
        <div class="grid-col-12 desktop:grid-col-8 order-2 pmc-layout__content">
            <div class="grid-container padding-left-0 padding-right-0">
                <div class="grid-row desktop:margin-left-neg-6">
                    <div class="grid-col-12">
                        <div class="pmc-layout__disclaimer" role="complementary" aria-label="Disclaimer note">
    As a library, NLM provides access to scientific literature. Inclusion in an NLM database does not imply endorsement of, or agreement with,
    the contents by NLM or the National Institutes of Health.<br/>
    Learn more:
    <a class="usa-link" data-ga-category="Link click" data-ga-action="Disclaimer" data-ga-label="New disclaimer box" href="/about/disclaimer/">PMC Disclaimer</a>
    |
    <a class="usa-link" data-ga-category="Link click" data-ga-action="PMC Copyright Notice" data-ga-label="New disclaimer box" href="/about/copyright/">
        PMC Copyright Notice
    </a>
</div>
                    </div>
                </div>
                <div class="grid-row pmc-wm desktop:margin-left-neg-6">
                    <!-- Main content -->
                    <main
                      id="main-content"
                      class="usa-layout-docs__main usa-layout-docs grid-col-12 pmc-layout pmc-prose padding-0"
                    >

                      
                        <section class="pmc-journal-banner text-center line-height-none" aria-label="Journal banner"><img src="https://cdn.ncbi.nlm.nih.gov/pmc/banners/logo-lwwopen.png" alt="Lippincott Open Access logo" usemap="#pmc-banner-imagemap" width="500" height="75"><map name="pmc-banner-imagemap"><area alt="Link to Lippincott Open Access" title="Link to Lippincott Open Access" shape="default" href="https://doi.org/10.1200/JCO.24.00905" target="_blank" rel="noopener noreferrer"></map></section><article lang="en"><section aria-label="Article citation and metadata"><section class="pmc-layout__citation font-secondary font-xs"><div>
<div class="display-inline-block"><button type="button" class="cursor-pointer text-no-underline bg-transparent border-0 padding-0 text-left margin-0 text-normal text-primary" aria-controls="journal_context_menu">J Clin Oncol</button></div>. 2025 May 22;43(19):2155–2163. doi: <a href="https://doi.org/10.1200/JCO.24.00905" class="usa-link usa-link--external" data-ga-action="click_feat_suppl" target="_blank" rel="noopener noreferrer">10.1200/JCO.24.00905</a>
</div>
<nav id="journal_context_menu" hidden="hidden"><ul class="menu-list font-family-ui" role="menu">
<li role="presentation"><a href="https://pmc.ncbi.nlm.nih.gov/search/?term=%22J%20Clin%20Oncol%22%5Bjour%5D" class="usa-link" role="menuitem">Search in PMC</a></li>
<li role="presentation"><a href="https://pubmed.ncbi.nlm.nih.gov/?term=%22J%20Clin%20Oncol%22%5Bjour%5D" lang="en" class="usa-link" role="menuitem">Search in PubMed</a></li>
<li role="presentation"><a href="https://www.ncbi.nlm.nih.gov/nlmcatalog?term=%22J%20Clin%20Oncol%22%5BTitle%20Abbreviation%5D" class="usa-link" role="menuitem">View in NLM Catalog</a></li>
<li role="presentation"><a href="?term=%22J%20Clin%20Oncol%22%5Bjour%5D" class="usa-link" role="menuitem" data-add-to-search="true">Add to search</a></li>
</ul></nav></section><section class="front-matter"><div class="ameta p font-secondary font-xs">
<hgroup><h1>Randomized Phase Ib Clinical Trial of DB-020 Intratympanic Injections to Reduce High-Dose Cisplatin Ototoxicity</h1></hgroup><div class="cg p">
<a href="https://pubmed.ncbi.nlm.nih.gov/?term=%22Panizza%20BJ%22%5BAuthor%5D" class="usa-link" aria-describedby="id1"><span class="name western">Benedict J Panizza</span></a><div hidden="hidden" id="id1">
<h3>
<span class="name western">Benedict J Panizza</span>, <span class="degrees">MBBS, MBA, FRACS, FACS</span>
</h3>
<div class="p">
<sup><sup>1</sup></sup>Princess Alexandra Hospital, Brisbane, Australia</div>
<div class="p">
<sup><sup>2</sup></sup>University of Queensland, Brisbane, Australia</div>
<div class="p">Find articles by <a href="https://pubmed.ncbi.nlm.nih.gov/?term=%22Panizza%20BJ%22%5BAuthor%5D" class="usa-link"><span class="name western">Benedict J Panizza</span></a>
</div>
</div>
<sup>1,</sup><sup>2</sup>, <a href="https://pubmed.ncbi.nlm.nih.gov/?term=%22O'Leary%20SJ%22%5BAuthor%5D" class="usa-link" aria-describedby="id2"><span class="name western">Stephen John O'Leary</span></a><div hidden="hidden" id="id2">
<h3>
<span class="name western">Stephen John O'Leary</span>, <span class="degrees">PhD, MBBS, BMedSci, FRACS</span>
</h3>
<div class="p">
<sup><sup>3</sup></sup>The University of Melbourne, Melbourne, Australia</div>
<div class="p">Find articles by <a href="https://pubmed.ncbi.nlm.nih.gov/?term=%22O'Leary%20SJ%22%5BAuthor%5D" class="usa-link"><span class="name western">Stephen John O'Leary</span></a>
</div>
</div>
<sup>3</sup>, <a href="https://pubmed.ncbi.nlm.nih.gov/?term=%22Hart%20CD%22%5BAuthor%5D" class="usa-link" aria-describedby="id3"><span class="name western">Christopher David Hart</span></a><div hidden="hidden" id="id3">
<h3>
<span class="name western">Christopher David Hart</span>, <span class="degrees">MBBS, BA, BSc, FRACP</span>
</h3>
<div class="p">
<sup><sup>4</sup></sup>St Vincent's Hospital Melbourne, Melbourne, Australia</div>
<div class="p">Find articles by <a href="https://pubmed.ncbi.nlm.nih.gov/?term=%22Hart%20CD%22%5BAuthor%5D" class="usa-link"><span class="name western">Christopher David Hart</span></a>
</div>
</div>
<sup>4</sup>, <a href="https://pubmed.ncbi.nlm.nih.gov/?term=%22Diwakarla%20CS%22%5BAuthor%5D" class="usa-link" aria-describedby="id4"><span class="name western">Chandra Sai Diwakarla</span></a><div hidden="hidden" id="id4">
<h3>
<span class="name western">Chandra Sai Diwakarla</span>, <span class="degrees">MBBS, BSc (Hons), FRACP</span>
</h3>
<div class="p">
<sup><sup>5</sup></sup>Fiona Stanley Hospital, Perth, Australia</div>
<div class="p">Find articles by <a href="https://pubmed.ncbi.nlm.nih.gov/?term=%22Diwakarla%20CS%22%5BAuthor%5D" class="usa-link"><span class="name western">Chandra Sai Diwakarla</span></a>
</div>
</div>
<sup>5</sup>, <a href="https://pubmed.ncbi.nlm.nih.gov/?term=%22Barnett%20C%22%5BAuthor%5D" class="usa-link" aria-describedby="id5"><span class="name western">Catherine Barnett</span></a><div hidden="hidden" id="id5">
<h3>
<span class="name western">Catherine Barnett</span>, <span class="degrees">MBBS, MPhil, MSc, BSc, FRACS</span>
</h3>
<div class="p">
<sup><sup>1</sup></sup>Princess Alexandra Hospital, Brisbane, Australia</div>
<div class="p">Find articles by <a href="https://pubmed.ncbi.nlm.nih.gov/?term=%22Barnett%20C%22%5BAuthor%5D" class="usa-link"><span class="name western">Catherine Barnett</span></a>
</div>
</div>
<sup>1</sup>, <a href="https://pubmed.ncbi.nlm.nih.gov/?term=%22Lapuerta%20P%22%5BAuthor%5D" class="usa-link" aria-describedby="id6"><span class="name western">Pablo Lapuerta</span></a><div hidden="hidden" id="id6">
<h3>
<span class="name western">Pablo Lapuerta</span>, <span class="degrees">MD</span>
</h3>
<div class="p">
<sup><sup>6</sup></sup>Lapuerta Consulting LLC, Skillman, NJ</div>
<div class="p">Find articles by <a href="https://pubmed.ncbi.nlm.nih.gov/?term=%22Lapuerta%20P%22%5BAuthor%5D" class="usa-link"><span class="name western">Pablo Lapuerta</span></a>
</div>
</div>
<sup>6,</sup><sup>✉</sup>, <a href="https://pubmed.ncbi.nlm.nih.gov/?term=%22Lee%20J%22%5BAuthor%5D" class="usa-link" aria-describedby="id7"><span class="name western">John Lee</span></a><div hidden="hidden" id="id7">
<h3>
<span class="name western">John Lee</span>, <span class="degrees">PhD</span>
</h3>
<div class="p">
<sup><sup>7</sup></sup>Decibel Therapeutics Inc, Boston, MA</div>
<div class="p">Find articles by <a href="https://pubmed.ncbi.nlm.nih.gov/?term=%22Lee%20J%22%5BAuthor%5D" class="usa-link"><span class="name western">John Lee</span></a>
</div>
</div>
<sup>7</sup>, <a href="https://pubmed.ncbi.nlm.nih.gov/?term=%22Raines%20S%22%5BAuthor%5D" class="usa-link" aria-describedby="id8"><span class="name western">Shane Raines</span></a><div hidden="hidden" id="id8">
<h3>
<span class="name western">Shane Raines</span>, <span class="degrees">MS</span>
</h3>
<div class="p">
<sup><sup>7</sup></sup>Decibel Therapeutics Inc, Boston, MA</div>
<div class="p">Find articles by <a href="https://pubmed.ncbi.nlm.nih.gov/?term=%22Raines%20S%22%5BAuthor%5D" class="usa-link"><span class="name western">Shane Raines</span></a>
</div>
</div>
<sup>7</sup>, <a href="https://pubmed.ncbi.nlm.nih.gov/?term=%22Quigley%20T%22%5BAuthor%5D" class="usa-link" aria-describedby="id9"><span class="name western">Tera Quigley</span></a><div hidden="hidden" id="id9">
<h3>
<span class="name western">Tera Quigley</span>, <span class="degrees">AuD</span>
</h3>
<div class="p">
<sup><sup>7</sup></sup>Decibel Therapeutics Inc, Boston, MA</div>
<div class="p">Find articles by <a href="https://pubmed.ncbi.nlm.nih.gov/?term=%22Quigley%20T%22%5BAuthor%5D" class="usa-link"><span class="name western">Tera Quigley</span></a>
</div>
</div>
<sup>7</sup>, <a href="https://pubmed.ncbi.nlm.nih.gov/?term=%22Wolff%20HM%22%5BAuthor%5D" class="usa-link" aria-describedby="id10"><span class="name western">Heather M Wolff</span></a><div hidden="hidden" id="id10">
<h3>
<span class="name western">Heather M Wolff</span>, <span class="degrees">BA</span>
</h3>
<div class="p">
<sup><sup>7</sup></sup>Decibel Therapeutics Inc, Boston, MA</div>
<div class="p">Find articles by <a href="https://pubmed.ncbi.nlm.nih.gov/?term=%22Wolff%20HM%22%5BAuthor%5D" class="usa-link"><span class="name western">Heather M Wolff</span></a>
</div>
</div>
<sup>7</sup>, <a href="https://pubmed.ncbi.nlm.nih.gov/?term=%22Keilty%20J%22%5BAuthor%5D" class="usa-link" aria-describedby="id11"><span class="name western">John Keilty</span></a><div hidden="hidden" id="id11">
<h3>
<span class="name western">John Keilty</span>, <span class="degrees">MS</span>
</h3>
<div class="p">
<sup><sup>7</sup></sup>Decibel Therapeutics Inc, Boston, MA</div>
<div class="p">Find articles by <a href="https://pubmed.ncbi.nlm.nih.gov/?term=%22Keilty%20J%22%5BAuthor%5D" class="usa-link"><span class="name western">John Keilty</span></a>
</div>
</div>
<sup>7</sup>, <a href="https://pubmed.ncbi.nlm.nih.gov/?term=%22Ladwa%20R%22%5BAuthor%5D" class="usa-link" aria-describedby="id12"><span class="name western">Rahul Ladwa</span></a><div hidden="hidden" id="id12">
<h3>
<span class="name western">Rahul Ladwa</span>, <span class="degrees">MBCHB, MPhil, BSc, FRACP</span>
</h3>
<div class="p">
<sup><sup>1</sup></sup>Princess Alexandra Hospital, Brisbane, Australia</div>
<div class="p">
<sup><sup>2</sup></sup>University of Queensland, Brisbane, Australia</div>
<div class="p">Find articles by <a href="https://pubmed.ncbi.nlm.nih.gov/?term=%22Ladwa%20R%22%5BAuthor%5D" class="usa-link"><span class="name western">Rahul Ladwa</span></a>
</div>
</div>
<sup>1,</sup><sup>2</sup>, <a href="https://pubmed.ncbi.nlm.nih.gov/?term=%22Porceddu%20SV%22%5BAuthor%5D" class="usa-link" aria-describedby="id13"><span class="name western">Sandro V Porceddu</span></a><div hidden="hidden" id="id13">
<h3>
<span class="name western">Sandro V Porceddu</span>, <span class="degrees">MD, MBBS, BSc, FRANZCR</span>
</h3>
<div class="p">
<sup><sup>8</sup></sup>Peter MacCallum Cancer Centre, Melbourne, Australia</div>
<div class="p">Find articles by <a href="https://pubmed.ncbi.nlm.nih.gov/?term=%22Porceddu%20SV%22%5BAuthor%5D" class="usa-link"><span class="name western">Sandro V Porceddu</span></a>
</div>
</div>
<sup>8</sup>, <a href="https://pubmed.ncbi.nlm.nih.gov/?term=%22McGrath%20M%22%5BAuthor%5D" class="usa-link" aria-describedby="id14"><span class="name western">Margaret McGrath</span></a><div hidden="hidden" id="id14">
<h3>
<span class="name western">Margaret McGrath</span>, <span class="degrees">FRACP</span>
</h3>
<div class="p">
<sup><sup>1</sup></sup>Princess Alexandra Hospital, Brisbane, Australia</div>
<div class="p">Find articles by <a href="https://pubmed.ncbi.nlm.nih.gov/?term=%22McGrath%20M%22%5BAuthor%5D" class="usa-link"><span class="name western">Margaret McGrath</span></a>
</div>
</div>
<sup>1</sup>, <a href="https://pubmed.ncbi.nlm.nih.gov/?term=%22Seetharamu%20N%22%5BAuthor%5D" class="usa-link" aria-describedby="id15"><span class="name western">Nagashree Seetharamu</span></a><div hidden="hidden" id="id15">
<h3>
<span class="name western">Nagashree Seetharamu</span>, <span class="degrees">MD, MBBS</span>
</h3>
<div class="p">
<sup><sup>9</sup></sup>Northwell Health, New Hyde Park, NY</div>
<div class="p">Find articles by <a href="https://pubmed.ncbi.nlm.nih.gov/?term=%22Seetharamu%20N%22%5BAuthor%5D" class="usa-link"><span class="name western">Nagashree Seetharamu</span></a>
</div>
</div>
<sup>9</sup>, <a href="https://pubmed.ncbi.nlm.nih.gov/?term=%22Fua%20T%22%5BAuthor%5D" class="usa-link" aria-describedby="id16"><span class="name western">Tsien Fua</span></a><div hidden="hidden" id="id16">
<h3>
<span class="name western">Tsien Fua</span>, <span class="degrees">MBBS, FRANZCR</span>
</h3>
<div class="p">
<sup><sup>2</sup></sup>University of Queensland, Brisbane, Australia</div>
<div class="p">Find articles by <a href="https://pubmed.ncbi.nlm.nih.gov/?term=%22Fua%20T%22%5BAuthor%5D" class="usa-link"><span class="name western">Tsien Fua</span></a>
</div>
</div>
<sup>2</sup>, <a href="https://pubmed.ncbi.nlm.nih.gov/?term=%22Rischin%20D%22%5BAuthor%5D" class="usa-link" aria-describedby="id17"><span class="name western">Danny Rischin</span></a><div hidden="hidden" id="id17">
<h3>
<span class="name western">Danny Rischin</span>, <span class="degrees">MD, MBBS</span>
</h3>
<div class="p">
<sup><sup>3</sup></sup>The University of Melbourne, Melbourne, Australia</div>
<div class="p">
<sup><sup>8</sup></sup>Peter MacCallum Cancer Centre, Melbourne, Australia</div>
<div class="p">Find articles by <a href="https://pubmed.ncbi.nlm.nih.gov/?term=%22Rischin%20D%22%5BAuthor%5D" class="usa-link"><span class="name western">Danny Rischin</span></a>
</div>
</div>
<sup>3,</sup><sup>8</sup>
</div>
<ul class="d-buttons inline-list">
<li><button class="d-button" aria-controls="aip_a" aria-expanded="false">Author information</button></li>
<li><button class="d-button" aria-controls="anp_a" aria-expanded="false">Article notes</button></li>
<li><button class="d-button" aria-controls="clp_a" aria-expanded="false">Copyright and License information</button></li>
</ul>
<div class="d-panels font-secondary-light">
<div id="aip_a" class="d-panel p" style="display: none">
<div class="p" id="aff1">
<sup><sup>1</sup></sup>Princess Alexandra Hospital, Brisbane, Australia</div>
<div id="aff2">
<sup><sup>2</sup></sup>University of Queensland, Brisbane, Australia</div>
<div id="aff3">
<sup><sup>3</sup></sup>The University of Melbourne, Melbourne, Australia</div>
<div id="aff4">
<sup><sup>4</sup></sup>St Vincent's Hospital Melbourne, Melbourne, Australia</div>
<div id="aff5">
<sup><sup>5</sup></sup>Fiona Stanley Hospital, Perth, Australia</div>
<div id="aff6">
<sup><sup>6</sup></sup>Lapuerta Consulting LLC, Skillman, NJ</div>
<div id="aff7">
<sup><sup>7</sup></sup>Decibel Therapeutics Inc, Boston, MA</div>
<div id="aff8">
<sup><sup>8</sup></sup>Peter MacCallum Cancer Centre, Melbourne, Australia</div>
<div id="aff9">
<sup><sup>9</sup></sup>Northwell Health, New Hyde Park, NY</div>
<div class="author-notes p"><div class="fn" id="cor1">
<sup>✉</sup><p class="display-inline">Pablo Lapuerta, MD; e-mail: <span>pablo@lapuertaconsulting.com</span>.</p>
</div></div>
</div>
<div id="anp_a" class="d-panel p" style="display: none"><div class="notes p"><section id="historyarticle-meta1" class="history"><p>Received 2024 Apr 26; Revised 2025 Feb 12; Accepted 2025 Mar 26; Issue date 2025 Jul 1.</p></section></div></div>
<div id="clp_a" class="d-panel p" style="display: none">
<div>© 2025 by American Society of Clinical Oncology</div>
<p>Creative Commons Attribution Non-Commercial No Derivatives 4.0 License: <a href="https://creativecommons.org/licenses/by-nc-nd/4.0/" class="usa-link usa-link--external" data-ga-action="click_feat_suppl" target="_blank" rel="noopener noreferrer">http://creativecommons.org/licenses/by-nc-nd/4.0/</a></p>
<div class="p"><a href="/about/copyright/" class="usa-link">PMC Copyright notice</a></div>
</div>
</div>
<div>PMCID: PMC12199801  PMID: <a href="https://pubmed.ncbi.nlm.nih.gov/40403227/" class="usa-link">40403227</a>
</div>
<div class="ra xbox p" role="complementary" aria-label="Related or updated information about this article"><div>See "<a href="https://pubmed.ncbi.nlm.nih.gov/40403204/" class="usa-link">Early phase trials in <em>Journal of Clinical Oncology</em></a>" on page 2139.</div></div>
</div></section></section><section aria-label="Article content"><section class="body main-article-body"><section class="abstract" id="abstract1"><h2>Abstract</h2>
<section id="sec1"><h3 class="pmc_sec_title">PURPOSE</h3>
<p>This study evaluated DB-020, a formulation of thiosulfate for intratympanic (IT) injection, in patients receiving high-dose cisplatin chemotherapy.</p></section><section id="sec2"><h3 class="pmc_sec_title">METHODS</h3>
<p>This randomized phase Ib clinical trial enrolled patients older than 18 years from five centers in Australia and the United States scheduled for at least three cycles of cisplatin and total cumulative exposure of ≥280 mg/m<sup>2</sup>. Patients received IT DB-020 (at a dose level of either 12% or 25%) in one ear and placebo in the other, once every 3 or 4 weeks, within 3 hours before receiving cisplatin. The primary end points were safety and tolerability, and the secondary end points included ototoxicity measured by air conduction audiometry. Ototoxicity was defined by American Speech-Language-Hearing Association criteria.</p></section><section id="sec3"><h3 class="pmc_sec_title">RESULTS</h3>
<p>Twenty-two patients with a median age of 55.1 years were randomly assigned and received a mean total cumulative cisplatin dose of 255 mg/m<sup>2</sup>. Mean number of cisplatin cycles was 2.3. Twenty patients had both baseline and follow-up audiometry. Ear pain of short duration was common after IT injection. There were no persistent tympanic perforations and no serious adverse events in the category of ear and labyrinth disorders. A progressive reduction in patient numbers was observed at each cycle due to patients ceasing cisplatin treatment. DB-020 treatment did not affect plasma thiosulfate concentrations. Ototoxicity after cisplatin administration was significantly more common in placebo-treated ears than in DB-020–treated ears (DB-020 <em>v</em> placebo, <em>P</em> = .0027). The incidence of ototoxicity (250-8,000 Hz) was 85.0% in placebo-treated ears, and 54.5% and 22.2% in ears treated with DB-020 12% and DB-020 25%, respectively.</p></section><section id="sec4"><h3 class="pmc_sec_title">CONCLUSION</h3>
<p>DB-020 IT injections were tolerated by patients and showed meaningful reductions in cisplatin ototoxicity.</p></section></section><section id="sec5"><h2 class="pmc_sec_title">INTRODUCTION</h2>
<p>DB-020 (sodium thiosulfate pentahydrate) is being developed for intratympanic (IT) injection to protect hearing in patients receiving cisplatin-based chemotherapy without interfering with cisplatin's anticancer activity, by chelating and inactivating cisplatin locally in the cochlea.<sup><a href="#b1" class="usa-link" aria-describedby="b1">1</a></sup> IT administration enables the release of otoprotectants into the middle ear, where the drug can cross the round window membrane to enter the inner ear and cochlea.<sup><a href="#b2" class="usa-link" aria-describedby="b2">2</a></sup> Cisplatin is a cornerstone chemotherapeutic agent that is widely used for a broad range of solid tumors.<sup><a href="#b3" class="usa-link" aria-describedby="b3">3</a></sup> Cisplatin administration is associated with severe dose-limiting toxicities, including the risk of ototoxicity from sensory hair cell loss in the cochlea of the inner ear.<sup><a href="#b4" class="usa-link" aria-describedby="b4">4</a></sup> The incidence of cisplatin-induced ototoxicity in adult patients with cancer has been estimated to be 36%.<sup><a href="#b5" class="usa-link" aria-describedby="b5">5</a></sup> Previous efforts to reduce cisplatin ototoxicity with IT injections failed to demonstrate benefit.<sup><a href="#b2" class="usa-link" aria-describedby="b2">2</a></sup> More recently, protective effects of IT steroids were demonstrated in preclinical studies.<sup><a href="#b6" class="usa-link" aria-describedby="b6">6</a></sup> Given cisplatin's foundational role in chemotherapy regimens, a reduction in cisplatin ototoxicity is needed to protect patients with cancer from permanent hearing loss.<sup><a href="#b3" class="usa-link" aria-describedby="b3">3</a>,<a href="#b7" class="usa-link" aria-describedby="b7">7</a></sup></p>
<section class="bt xbox font-sm" id="B1"><section id="sec6"><h3 class="pmc_sec_title">CONTEXT</h3>
<ul class="list" style="list-style-type:none">
<li><p>
<strong>Key Objective</strong>
</p></li>
<li><p>This study evaluated the safety, tolerability, and efficacy of intratympanic (IT) DB-020 administered to adult patients with cancer receiving cisplatin.</p></li>
<li><p>
<strong>Knowledge Generated</strong>
</p></li>
<li><p>DB-020 IT injections resulted in significant reductions in cisplatin ototoxicity with no apparent impact on plasma concentrations of free cisplatin. No persistent tympanic perforations and no serious adverse events related to ear and labyrinth disorders were reported. These findings support DB-020 25% as an appropriate dose for future clinical trials.</p></li>
<li><p>
<strong>Relevance <em>(R.G. Maki)</em></strong>
</p></li>
<li><p>While execution on such an injection plan beyond this trial will require training, this well-designed trial confirmed that hearing can be protected through use of transtympanic thiosulfate injections. These data appear to demonstrate a material and genuine advance to help protect organ function in patients who receive high-dose cisplatin with curative intent.*</p></li>
<li><p>*Relevance section written by <em>JCO</em> Associate Editor Robert G. Maki, MD, PhD, FACP, FASCO.</p></li>
</ul></section></section><p>There are currently no approved drugs to protect against cisplatin ototoxicity in adults. Intravenously (IV) administered thiosulfate (Pedmark, Fennec Pharmaceuticals, Durham, NC) has received approval from the US Food and Drug Administration for use in pediatric patients to reduce the risk of cisplatin-associated ototoxicity.<sup><a href="#b8" class="usa-link" aria-describedby="b8">8</a></sup> Thiosulfate requires a high dose (16-20 g/m<sup>2</sup>) administered IV,<sup><a href="#b9" class="usa-link" aria-describedby="b9">9</a></sup> whereas DB-020 is delivered by IT injection.<sup><a href="#b1" class="usa-link" aria-describedby="b1">1</a></sup> IT injection offers the potential to reduce ototoxicity without diminishing the intended antitumor effects provided by systemic cisplatin exposure.<sup><a href="#b9" class="usa-link" aria-describedby="b9">9</a></sup></p>
<p>The safety, tolerability, and systemic pharmacokinetics (PK) of DB-020 were previously evaluated in a phase I study in healthy volunteers (Study DB-020-001)<sup><a href="#b1" class="usa-link" aria-describedby="b1">1</a></sup> in which no serious treatment-emergent adverse events (TEAEs) or discontinuations occurred due to adverse events (AEs). To our knowledge, the current study (DB-020-002) was the first evaluation of DB-020 in chemo-naïve patients with cancer receiving cisplatin. The primary objective was to evaluate safety and tolerability through the incidence of AEs; vital signs; electrocardiogram results; clinical laboratory assessments; otoscopy examination results; and follow-up disease status. Secondary objectives included evaluation of efficacy in DB-020–treated compared with placebo-treated ears using the incidence of American Speech-Language-Hearing Association (ASHA)–defined ototoxicity, followed by other changes in pure tone audiometry,<sup><a href="#b10" class="usa-link" aria-describedby="b10">10</a></sup> Speech Intelligibility Index (SII),<sup><a href="#b11" class="usa-link" aria-describedby="b11">11</a></sup> distortion product otoacoustic emissions (DPOAEs),<sup><a href="#b12" class="usa-link" aria-describedby="b12">12</a></sup> Words in Noise (WIN) test,<sup><a href="#b13" class="usa-link" aria-describedby="b13">13</a></sup> tympanometry,<sup><a href="#b14" class="usa-link" aria-describedby="b14">14</a></sup> and Hearing Handicap Inventory for Adults (HHIA; Data Supplement, Appendix S1, online only).<sup><a href="#b15" class="usa-link" aria-describedby="b15">15</a></sup> Plasma levels of DB-020 and PK of free (unbound) cisplatin were also assessed.</p></section><section id="sec7"><h2 class="pmc_sec_title">METHODS</h2>
<section id="sec8"><h3 class="pmc_sec_title">Study Design and Eligibility</h3>
<p>This was a phase Ib, randomized, double-blind, placebo-controlled clinical trial conducted at five centers in Australia and the United States. Patients were over 18 years of age and were scheduled to receive a total cumulative cisplatin dose of ≥280 mg/m<sup>2</sup> over at least three cycles (once every 21 days or once every 28 days) for the treatment of cancer of any type. All patients had an Eastern Cooperative Oncology Group<sup><a href="#b16" class="usa-link" aria-describedby="b16">16</a></sup> performance status of 0 to 2, and an anticipated survival of &gt;1 year. Concomitant use of other chemotherapy and radiation was permitted except for investigational agents and/or radiation &gt;35 Gy involving the cochlear region. Patients with hearing loss of &gt;45 dB averaged over 6 and 8 kHz in either ear were excluded. Additional inclusion and exclusion criteria are provided in the Data Supplement (Appendices S2 and S3).</p>
<p>The study complied with the Declaration of Helsinki, International Council for Harmonisation Good Clinical Practice, local laws, and regulatory requirements. Independent ethics committees or institutional review boards approved the protocol. Patients provided written informed consent.</p></section><section id="sec9"><h3 class="pmc_sec_title">Study Procedures and Treatment</h3>
<p>Eligible patients were randomly assigned to receive double-blinded, bilateral IT injections with DB-020 in one ear and placebo (a solution of sodium hyaluronate in 0.9% sodium chloride) in the other, allowing each patient to serve as their own control. The randomization scheme included a block size of 4. Randomization assignments included DB-020 12% w/v (0.5 M) in the right ear, DB-020 12% w/v (0.5 M) in the left ear, DB-020 25% w/v (1 M) in the right ear, and DB-020 25% w/v (1 M) in the left ear, with placebo assigned to the non–DB-020 ear for each patient (Data Supplement, Table S7). The same ear assignments (left or right) for DB-020 and placebo were maintained throughout the treatment period. The dose levels of 0.5 and 1.0 M were selected because they were well tolerated in the phase I DB-020-001 study and were supported by results from nonclinical toxicology studies. Additionally, these doses were predicted to achieve efficacious (ie, protective) DB-020 concentrations on the basis of preclinical pharmacology and PK results.</p>
<p>IT injections were administered once every 3 or 4 weeks, according to the cisplatin dosing schedule (entirely in single-day infusion regimens given as close as possible before cisplatin administration). Additional details about the clinical procedure of DB-020 administration are provided in the Data Supplement (Appendix S4).</p>
<p>All AEs were recorded, regardless of their relationship to study drug. Investigators rated AEs on a study-specific severity scale of mild (awareness of sign or symptom, but easily tolerated), moderate (discomfort sufficient to interfere with normal activities), and severe (incapacitating, with inability to perform normal activities); they also assessed AE relationship to the IT injection and/or study drug. Additional safety measures and various efficacy assessments were performed at each clinic visit.</p>
<p>The key time point was the end-of-treatment (EOT) outcome after completion of all chemotherapy, examined with the last observation carried forward (LOCF) approach (Data Supplement, Appendix S5). This was chosen because patients were expected to differ in the total number of cycles of chemotherapy, with toxicity progressing over multiple cycles.</p>
<p>Ototoxicity was defined by ASHA criteria.<sup><a href="#b10" class="usa-link" aria-describedby="b10">10</a></sup> ASHA defines an ototoxic change if one of the following criteria are met: (1) a ≥20-dB increase in audiometric threshold at any one test frequency, (2) a ≥10-dB increase in threshold at any two adjacent frequencies, or (3) loss of response at three consecutive frequencies where responses were previously obtained. ASHA criteria were chosen because of their broad acceptance and clinical relevance. Severe ototoxicity was defined as a ≥20-dB increase in measured threshold at any two adjacent frequencies.</p>
<p>Approximately 50 patients were planned to be randomly assigned to provide at least 25 patients with total cumulative cisplatin exposure of ≥280 mg/m<sup>2</sup> at each dose level with a 70% power to detect a difference in the proportion of ototoxicity between DB-020–treated and placebo-treated ears at a two-sided significance level of 0.05, assuming a 0.60 ototoxicity rate for placebo and a 0.24 ototoxicity rate for DB-020.</p>
<p>An interim analysis was planned to take place when about 20 patients completed both baseline and follow-up audiograms (after ≥1 cisplatin cycle). The interim analysis was done when 19 patients had available data, because a blinded review indicated higher rates of discordance in ototoxicity than expected between ears. The interim analysis was performed by an independent statistician at the contract research organization (CRO). Only select sponsor personnel were unblinded to the results; all other sponsor personnel, the CRO staff, site staff, and patients remained blinded until study completion.</p>
<p>Recruitment was stopped after the interim analysis because study objectives were met. Three patients who were already in the study completed their participation, leading to 22 patients enrolled overall.</p>
<p>Pure tone threshold assessments were carried out at frequencies ranging from 250 to 16,000 Hz for air conduction audiometry and 250 to 4,000 Hz for bone conduction audiometry.</p></section><section id="sec10"><h3 class="pmc_sec_title">Statistics</h3>
<p>For measurement of safety outcomes, all patients who received at least one dose of DB-020 were considered evaluable. For efficacy outcomes, patients were defined as evaluable if they had at least one baseline and one follow-up hearing assessment. LOCF ototoxicity values from the DB-020–treated ears were compared with placebo-treated ears using McNemar's test (Data Supplement, Appendix S5). To account for multiplicity, this key efficacy assessment of ototoxicity was tested sequentially, first with the DB-020 25% dose versus placebo, and then with the DB-020 12% dose versus placebo.</p>
<p>Ototoxicity between ears was also examined using the Wilcoxon signed-rank test. Other efficacy assessments were analyzed using mixed model with repeated measures (MMRM) and analysis of covariance (ANCOVA). Specifically, both MMRM and ANCOVA methods were used for air conduction threshold change from baseline, shift results, and SII results; MMRM was used for bone conduction threshold results; and ANCOVA was used for DPOAEs and WIN results (Data Supplement, Appendix S6). All efficacy assessments were summarized using descriptive statistics.</p></section></section><section id="sec11"><h2 class="pmc_sec_title">RESULTS</h2>
<section id="sec12"><h3 class="pmc_sec_title">Disposition and Demographics</h3>
<p>The completed study included 22 patients enrolled between February 17, 2020, and May 17, 2022.</p>
<p>An overview of patient disposition is shown in Figure <a href="#fig1" class="usa-link">1</a>. All patients received DB-020 within 3 hours of their cisplatin treatment, except for one who received DB-020 almost 4 hours before cisplatin treatment. This patient experienced ototoxicity in their placebo-treated ear and not in the DB-020–treated ear during this cycle. Eleven patients (50.0%) did not complete at least three doses of the study drug. One patient only received one injection of DB-020 in one ear and withdrew before receiving the injection of placebo in the other ear. This patient is included in all summaries because they had one treated ear and one untreated ear. All patients completed the EOT visit. Fourteen patients (63.6%) completed the 1-year follow up. Four patients (18.2%) withdrew from the study before the 1-year follow-up. One death occurred outside the safety reporting period (Data Supplement, Appendix S7).</p>
<figure class="fig xbox font-sm" id="fig1"><h4 class="obj_head">FIG 1.</h4>
<p class="img-box line-height-none margin-x-neg-2 tablet:margin-x-0 text-center"><img class="graphic" src="https://cdn.ncbi.nlm.nih.gov/pmc/blobs/52b1/12199801/3ba5ff1b7f0f/jco-43-2155-g001.jpg" loading="lazy" height="3643" width="4149" alt="FIG 1."></p>
<div class="p text-right font-secondary"><a href="figure/fig1/" class="usa-link" target="_blank" rel="noopener noreferrer">Open in a new tab</a></div>
<figcaption><p>CONSORT diagram. ICF, informed consent form; LOCF, last observation carried forward; SAE, serious adverse event.</p></figcaption></figure><p>The median patient age was 55.1 years; 86.4% were male. All patients were White. There was consistency in demographics and other baseline characteristics across randomized treatment groups (Table <a href="#tbl1" class="usa-link">1</a>).</p>
<section class="tw xbox font-sm" id="tbl1"><h4 class="obj_head">TABLE 1.</h4>
<div class="caption p"><p>Demographics and Other Baseline Characteristics</p></div>
<div class="tbl-box p" tabindex="0"><table class="content" frame="hsides" rules="groups">
<thead valign="bottom"><tr>
<th rowspan="1" colspan="1">Demographic Characteristic</th>
<th align="center" rowspan="1" colspan="1">DB-020<br>12% Right Ear (n = 7)</th>
<th align="center" rowspan="1" colspan="1">DB-020<br>12% Left Ear (n = 4)</th>
<th align="center" rowspan="1" colspan="1">DB-020<br>25% Right Ear (n = 5)</th>
<th align="center" rowspan="1" colspan="1">DB-020<br>25% Left Ear (n = 6)</th>
<th align="center" rowspan="1" colspan="1">Overall (N = 22)</th>
</tr></thead>
<tbody valign="top">
<tr>
<td rowspan="1" colspan="1">Age at consent, years</td>
<td rowspan="1" colspan="1"></td>
<td rowspan="1" colspan="1"></td>
<td rowspan="1" colspan="1"></td>
<td rowspan="1" colspan="1"></td>
<td rowspan="1" colspan="1"></td>
</tr>
<tr>
<td rowspan="1" colspan="1"> Mean (SD)</td>
<td align="center" rowspan="1" colspan="1">56.7 (12.76)</td>
<td align="center" rowspan="1" colspan="1">56.0 (6.78)</td>
<td align="center" rowspan="1" colspan="1">53.4 (6.23)</td>
<td align="center" rowspan="1" colspan="1">54.0 (12.95)</td>
<td align="center" rowspan="1" colspan="1">55.1 (10.12)</td>
</tr>
<tr>
<td rowspan="1" colspan="1"> Median</td>
<td align="center" rowspan="1" colspan="1">62.0</td>
<td align="center" rowspan="1" colspan="1">53.5</td>
<td align="center" rowspan="1" colspan="1">54.0</td>
<td align="center" rowspan="1" colspan="1">53.0</td>
<td align="center" rowspan="1" colspan="1">54.0</td>
</tr>
<tr>
<td rowspan="1" colspan="1"> Min, max</td>
<td align="center" rowspan="1" colspan="1">37, 71</td>
<td align="center" rowspan="1" colspan="1">51, 66</td>
<td align="center" rowspan="1" colspan="1">46, 62</td>
<td align="center" rowspan="1" colspan="1">35, 69</td>
<td align="center" rowspan="1" colspan="1">35, 71</td>
</tr>
<tr>
<td rowspan="1" colspan="1">Sex, No. (%)</td>
<td rowspan="1" colspan="1"></td>
<td rowspan="1" colspan="1"></td>
<td rowspan="1" colspan="1"></td>
<td rowspan="1" colspan="1"></td>
<td rowspan="1" colspan="1"></td>
</tr>
<tr>
<td rowspan="1" colspan="1"> Male</td>
<td align="center" rowspan="1" colspan="1">5 (71.4)</td>
<td align="center" rowspan="1" colspan="1">4 (100)</td>
<td align="center" rowspan="1" colspan="1">5 (100)</td>
<td align="center" rowspan="1" colspan="1">5 (83.3)</td>
<td align="center" rowspan="1" colspan="1">19 (86.4)</td>
</tr>
<tr>
<td rowspan="1" colspan="1"> Female</td>
<td align="center" rowspan="1" colspan="1">2 (28.6)</td>
<td align="center" rowspan="1" colspan="1">0</td>
<td align="center" rowspan="1" colspan="1">0</td>
<td align="center" rowspan="1" colspan="1">1 (16.7)</td>
<td align="center" rowspan="1" colspan="1">3 (13.6)</td>
</tr>
<tr>
<td rowspan="1" colspan="1">Race, No. (%)</td>
<td rowspan="1" colspan="1"></td>
<td rowspan="1" colspan="1"></td>
<td rowspan="1" colspan="1"></td>
<td rowspan="1" colspan="1"></td>
<td rowspan="1" colspan="1"></td>
</tr>
<tr>
<td rowspan="1" colspan="1"> White</td>
<td align="center" rowspan="1" colspan="1">7 (100)</td>
<td align="center" rowspan="1" colspan="1">4 (100)</td>
<td align="center" rowspan="1" colspan="1">5 (100)</td>
<td align="center" rowspan="1" colspan="1">6 (100)</td>
<td align="center" rowspan="1" colspan="1">22 (100)</td>
</tr>
<tr>
<td rowspan="1" colspan="1">Ethnicity, No. (%)</td>
<td rowspan="1" colspan="1"></td>
<td rowspan="1" colspan="1"></td>
<td rowspan="1" colspan="1"></td>
<td rowspan="1" colspan="1"></td>
<td rowspan="1" colspan="1"></td>
</tr>
<tr>
<td rowspan="1" colspan="1"> Not Hispanic or Latino</td>
<td align="center" rowspan="1" colspan="1">6 (85.7)</td>
<td align="center" rowspan="1" colspan="1">3 (75.0)</td>
<td align="center" rowspan="1" colspan="1">5 (100)</td>
<td align="center" rowspan="1" colspan="1">5 (83.3)</td>
<td align="center" rowspan="1" colspan="1">19 (86.4)</td>
</tr>
<tr>
<td rowspan="1" colspan="1"> Unknown</td>
<td align="center" rowspan="1" colspan="1">1 (14.3)</td>
<td align="center" rowspan="1" colspan="1">1 (25.0)</td>
<td align="center" rowspan="1" colspan="1">0</td>
<td align="center" rowspan="1" colspan="1">1 (16.7)</td>
<td align="center" rowspan="1" colspan="1">3 (13.6)</td>
</tr>
<tr>
<td rowspan="1" colspan="1">ECOG performance status, No. (%)</td>
<td rowspan="1" colspan="1"></td>
<td rowspan="1" colspan="1"></td>
<td rowspan="1" colspan="1"></td>
<td rowspan="1" colspan="1"></td>
<td rowspan="1" colspan="1"></td>
</tr>
<tr>
<td rowspan="1" colspan="1"> 0</td>
<td align="center" rowspan="1" colspan="1">7 (100)</td>
<td align="center" rowspan="1" colspan="1">4 (100)</td>
<td align="center" rowspan="1" colspan="1">5 (100)</td>
<td align="center" rowspan="1" colspan="1">5 (83.3)</td>
<td align="center" rowspan="1" colspan="1">21 (95.5)</td>
</tr>
<tr>
<td rowspan="1" colspan="1"> 1</td>
<td align="center" rowspan="1" colspan="1">0</td>
<td align="center" rowspan="1" colspan="1">0</td>
<td align="center" rowspan="1" colspan="1">0</td>
<td align="center" rowspan="1" colspan="1">1 (16.7)</td>
<td align="center" rowspan="1" colspan="1">1 (4.5)</td>
</tr>
<tr>
<td rowspan="1" colspan="1">Neoplasms benign, malignant, and unspecified, No. (%)</td>
<td align="center" rowspan="1" colspan="1">6 (85.7)<a href="#tblfn1" class="usa-link"><sup>a</sup></a>
</td>
<td align="center" rowspan="1" colspan="1">4 (100)</td>
<td align="center" rowspan="1" colspan="1">5 (100)</td>
<td align="center" rowspan="1" colspan="1">6 (100)</td>
<td align="center" rowspan="1" colspan="1">21 (95.5)</td>
</tr>
<tr>
<td rowspan="1" colspan="1"> Tonsil cancer</td>
<td align="center" rowspan="1" colspan="1">3 (42.9)</td>
<td align="center" rowspan="1" colspan="1">2 (50.0)</td>
<td align="center" rowspan="1" colspan="1">4 (80.0)</td>
<td align="center" rowspan="1" colspan="1">3 (50.0)</td>
<td align="center" rowspan="1" colspan="1">12 (54.5)</td>
</tr>
<tr>
<td rowspan="1" colspan="1"> Squamous cell carcinoma of the tongue</td>
<td align="center" rowspan="1" colspan="1">1 (14.3)</td>
<td align="center" rowspan="1" colspan="1">1 (25.0)</td>
<td align="center" rowspan="1" colspan="1">1 (20.0)</td>
<td align="center" rowspan="1" colspan="1">1 (16.7)</td>
<td align="center" rowspan="1" colspan="1">4 (18.2)</td>
</tr>
<tr>
<td rowspan="1" colspan="1"> Oropharyngeal squamous cell carcinoma</td>
<td align="center" rowspan="1" colspan="1">0</td>
<td align="center" rowspan="1" colspan="1">1 (25.0)</td>
<td align="center" rowspan="1" colspan="1">0</td>
<td align="center" rowspan="1" colspan="1">1 (16.7)</td>
<td align="center" rowspan="1" colspan="1">2 (9.1)</td>
</tr>
<tr>
<td rowspan="1" colspan="1"> Squamous cell carcinoma</td>
<td align="center" rowspan="1" colspan="1">1 (14.3)</td>
<td align="center" rowspan="1" colspan="1">0</td>
<td align="center" rowspan="1" colspan="1">0</td>
<td align="center" rowspan="1" colspan="1">1 (16.7)</td>
<td align="center" rowspan="1" colspan="1">2 (9.1)</td>
</tr>
<tr>
<td rowspan="1" colspan="1"> Basal cell carcinoma</td>
<td align="center" rowspan="1" colspan="1">0</td>
<td align="center" rowspan="1" colspan="1">0</td>
<td align="center" rowspan="1" colspan="1">0</td>
<td align="center" rowspan="1" colspan="1">1 (16.7)</td>
<td align="center" rowspan="1" colspan="1">1 (4.5)</td>
</tr>
<tr>
<td rowspan="1" colspan="1"> Lung neoplasm malignant</td>
<td align="center" rowspan="1" colspan="1">1 (14.3)</td>
<td align="center" rowspan="1" colspan="1">0</td>
<td align="center" rowspan="1" colspan="1">0</td>
<td align="center" rowspan="1" colspan="1">0</td>
<td align="center" rowspan="1" colspan="1">1 (4.5)</td>
</tr>
<tr>
<td rowspan="1" colspan="1"> Malignant melanoma</td>
<td align="center" rowspan="1" colspan="1">0</td>
<td align="center" rowspan="1" colspan="1">0</td>
<td align="center" rowspan="1" colspan="1">0</td>
<td align="center" rowspan="1" colspan="1">1 (16.7)</td>
<td align="center" rowspan="1" colspan="1">1 (4.5)</td>
</tr>
<tr>
<td rowspan="1" colspan="1"> Oral cavity cancer metastatic</td>
<td align="center" rowspan="1" colspan="1">0</td>
<td align="center" rowspan="1" colspan="1">0</td>
<td align="center" rowspan="1" colspan="1">0</td>
<td align="center" rowspan="1" colspan="1">1 (16.7)</td>
<td align="center" rowspan="1" colspan="1">1 (4.5)</td>
</tr>
<tr>
<td rowspan="1" colspan="1"> Oropharyngeal cancer</td>
<td align="center" rowspan="1" colspan="1">1 (14.3)</td>
<td align="center" rowspan="1" colspan="1">0</td>
<td align="center" rowspan="1" colspan="1">0</td>
<td align="center" rowspan="1" colspan="1">0</td>
<td align="center" rowspan="1" colspan="1">1 (4.5)</td>
</tr>
</tbody>
</table></div>
<div class="p text-right font-secondary"><a href="table/tbl1/" class="usa-link" target="_blank" rel="noopener noreferrer">Open in a new tab</a></div>
<div class="tw-foot p">
<div class="fn" id="fn1"><p>NOTE. Percentages are calculated as n/N*100.</p></div>
<div class="fn" id="fn2"><p>Abbreviations: ECOG, Eastern Cooperative Oncology Group; ITT, intention-to-treat; SD, standard deviation.</p></div>
<div class="fn" id="tblfn1">
<sup>
<sup>a</sup>
</sup><p class="display-inline">One patient without a medical history term for neoplasm had a tonsillectomy shortly before enrollment.</p>
</div>
</div></section></section><section id="sec13"><h3 class="pmc_sec_title">Safety</h3>
<p>All patients experienced at least one TEAE. The most common TEAEs by preferred term were ear pain (n = 18, 81.8%), nausea (n = 16, 72.7%), constipation (n = 13, 59.1%), tinnitus (n = 11, 50.0%), and dysgeusia (n = 9, 40.9%). See the Data Supplement (Table S1) for a full description.</p>
<p>For all occurrences of ear pain, the date of onset and the date of resolution were the same, with the exception of one patient. This patient reported mild pain in the left ear (assigned to placebo), with onset 2 weeks after IT injection and no resolution date. For the other patients, ear pain related to injections lasted a median duration of 10 minutes after injection (range, 2-65 minutes).</p>
<p>AE reports for ear pain and tinnitus (except for one case of tinnitus, which was included below as affecting both ears) indicated which ear was involved, allowing incidences in placebo-treated ears to be determined. The incidence of ear pain was 13.6% in placebo-treated ears and 77.3% in DB-020–treated ears. The incidence of tinnitus was greater in placebo-treated ears (50.0%) than in DB-020–treated ears (13.6%; Table <a href="#tbl2" class="usa-link">2</a>).</p>
<section class="tw xbox font-sm" id="tbl2"><h4 class="obj_head">TABLE 2.</h4>
<div class="caption p"><p>Ear Pain and Tinnitus Treatment-Emergent Adverse Events by Treatment</p></div>
<div class="tbl-box p" tabindex="0"><table class="content" frame="hsides" rules="groups">
<thead valign="bottom"><tr>
<th rowspan="1" colspan="1">Preferred Term</th>
<th align="center" rowspan="1" colspan="1">Placebo (N = 22), No. (%)</th>
<th align="center" rowspan="1" colspan="1">DB-020 12% (n = 11), No. (%)</th>
<th align="center" rowspan="1" colspan="1">DB-020 25% (n = 11), No. (%)</th>
<th align="center" rowspan="1" colspan="1">DB-020 (N = 22), No. (%)</th>
</tr></thead>
<tbody valign="top">
<tr>
<td rowspan="1" colspan="1">Ear pain</td>
<td align="center" rowspan="1" colspan="1">3 (14)</td>
<td align="center" rowspan="1" colspan="1">8 (73)</td>
<td align="center" rowspan="1" colspan="1">9 (82)</td>
<td align="center" rowspan="1" colspan="1">17 (77)</td>
</tr>
<tr>
<td rowspan="1" colspan="1">Tinnitus</td>
<td align="center" rowspan="1" colspan="1">11 (50)</td>
<td align="center" rowspan="1" colspan="1">0 (0)</td>
<td align="center" rowspan="1" colspan="1">3 (27)</td>
<td align="center" rowspan="1" colspan="1">3 (14)</td>
</tr>
</tbody>
</table></div>
<div class="p text-right font-secondary"><a href="table/tbl2/" class="usa-link" target="_blank" rel="noopener noreferrer">Open in a new tab</a></div></section><p>Eight patients (36.4%) experienced a total of 14 serious AEs (SAEs), all of which were considered not related to study drug or IT injection (Data Supplement, Table S2). The most frequent SAE was acute kidney injury (two patients [9.1%]); no other SAEs occurred in more than one patient. There were no clinically significant findings for clinical laboratory assessments or vital signs. Otoscopy results showed no tympanic membrane perforations. No AEs led to death during this study.</p></section><section id="sec14"><h3 class="pmc_sec_title">Exposure</h3>
<p>The mean total cumulative cisplatin dose for all patients was 255 mg/m<sup>2</sup>, and the mean number of cisplatin cycles was 2.3. DB-020 exposure by assessment time point is summarized in the Data Supplement (Table S3). On cycle 1 day 1, all patients (22/22) were exposed to DB-020; this decreased to 72.7% (16/22) on cycle 2 day 1 and 50.0% (11/22) on cycle 3 day 1, and only one patient received a fourth DB-020 treatment (4.5% [1/22] on cycle 4 day 1; Data Supplement, Table S3). The number of patients in the four treatment groups was similar at seven, four, five, and six patients for DB-020 12% in the right ear, DB-020 in the 12% left ear, DB-020 in the 25% right ear, and DB-020 in the 25% left ear, respectively. The progressive reduction in patient numbers at each cycle was due to patients ceasing cisplatin treatment rather than withdrawing from DB-020 treatment, and it reflects the challenges of tolerating cisplatin therapy. Two patients withdrew because of ear pain after receiving one dose of DB-020 25%.</p></section><section id="sec15"><h3 class="pmc_sec_title">Pharmacokinetics</h3>
<p>DB-020 did not affect endogenous plasma concentrations of thiosulfate. Before DB-020 and placebo administration, mean endogenous thiosulfate plasma concentrations were 400 and 570 ng/mL in patients treated with DB-020 12% and DB-020 25%, respectively. Fifteen minutes before the cisplatin dose, mean thiosulfate plasma concentrations were 393 and 530 ng/mL in patients treated with DB-020 12% and DB-020 25%, respectively.</p>
<p>Mean unbound cisplatin concentrations were 1,928 and 2,061 ng/mL with DB-020 12% and DB-020 25% treatment at the end of infusion on cycle 1 day 1, respectively.</p></section><section id="sec16"><h3 class="pmc_sec_title">Ototoxicity</h3>
<p>Across various time points, the highest incidence of ototoxicity was in placebo-treated ears, with an intermediate incidence in ears treated with DB-020 12.5% and the lowest incidence in ears treated with DB-020 25%. ASHA ototoxicity rates at LOCF for the 250-8,000 Hz frequency range showed a dose response, with 85.0%, 54.5%, and 22.2% ototoxicity incidence in ears treated with placebo, DB-020 12%, and DB-020 25%, respectively (<em>P</em> = .0454 for DB-020 12% <em>v</em> placebo and <em>P</em> = .0253 for DB-020 25% <em>v</em> placebo using McNemar's test; Fig <a href="#fig2" class="usa-link">2</a>). A reduction in ototoxicity was observed after single treatment with DB-020 at the beginning of cycle 2, with an ototoxicity rate of 70.0% for placebo-treated ears versus 15.0% for DB-020–treated ears (ASHA criteria, 250-8,000 Hz; Data Supplement, Tables S4 and S5). Significantly lower incidences of ototoxicity and severe ototoxicity were seen with DB-020 in the frequency ranges of 250-8,000 Hz and 9,000-16,000 Hz, respectively (Table <a href="#tbl3" class="usa-link">3</a>). Between-ear ototoxicity using Wilcox signed-rank test showed a similar trend (Data Supplement, Table S6). The average threshold shift averaged over 4,000-8,000 Hz was greater in placebo-treated ears (least-squares mean of 30.22 dB) than in ears treated with DB020 12% (10.24 dB) or DB-020 25% (5.23 dB). Mean audiogram plots by treatment show that the change in hearing levels from baseline to LOCF was greater for patients treated with placebo (Fig <a href="#fig3" class="usa-link">3</a>).</p>
<figure class="fig xbox font-sm" id="fig2"><h4 class="obj_head">FIG 2.</h4>
<p class="img-box line-height-none margin-x-neg-2 tablet:margin-x-0 text-center"><a class="tileshop" target="_blank" href="https://www.ncbi.nlm.nih.gov/core/lw/2.0/html/tileshop_pmc/tileshop_pmc_inline.html?title=Click%20on%20image%20to%20zoom&amp;p=PMC3&amp;id=12199801_jco-43-2155-g002.jpg"><img class="graphic zoom-in" src="https://cdn.ncbi.nlm.nih.gov/pmc/blobs/52b1/12199801/7d1c63b54eb0/jco-43-2155-g002.jpg" loading="lazy" height="558" width="813" alt="FIG 2."></a></p>
<div class="p text-right font-secondary"><a href="figure/fig2/" class="usa-link" target="_blank" rel="noopener noreferrer">Open in a new tab</a></div>
<figcaption><p>Ototoxicity at LOCF: ASHA criteria applied to the 250-8,000 Hz frequency range. <em>P</em> = .0454 for DB-020 12% versus placebo and <em>P</em> = .0253 for DB-020 25% versus placebo using McNemar's test. ASHA, American Speech-Language-Hearing Association; LOCF, last observation carried forward.</p></figcaption></figure><section class="tw xbox font-sm" id="tbl3"><h4 class="obj_head">TABLE 3.</h4>
<div class="caption p"><p>Summary of Ototoxicity Assessments for Combined DB-020 Treatment Versus Placebo at End of Treatment Visit (LOCF)</p></div>
<div class="tbl-box p" tabindex="0"><table class="content" frame="hsides" rules="groups">
<thead valign="bottom"><tr>
<th rowspan="1" colspan="1">Assessment</th>
<th align="center" rowspan="1" colspan="1">Placebo Ears (N = 20)</th>
<th align="center" rowspan="1" colspan="1">DB-020 Ears (N = 20)</th>
<th align="center" rowspan="1" colspan="1">
<em>P</em><br>DB-020 <em>v</em> Placebo</th>
</tr></thead>
<tbody valign="top">
<tr>
<td rowspan="1" colspan="1">Ototoxicity (250-8,000 Hz), %</td>
<td align="center" rowspan="1" colspan="1">85</td>
<td align="center" rowspan="1" colspan="1">40</td>
<td align="center" rowspan="1" colspan="1">.0027</td>
</tr>
<tr>
<td rowspan="1" colspan="1">Ototoxicity (9,000-16,000 Hz), %</td>
<td align="center" rowspan="1" colspan="1">90</td>
<td align="center" rowspan="1" colspan="1">60</td>
<td align="center" rowspan="1" colspan="1">.0143</td>
</tr>
<tr>
<td rowspan="1" colspan="1">Severe ototoxicity (250-8,000 Hz), %</td>
<td align="center" rowspan="1" colspan="1">70</td>
<td align="center" rowspan="1" colspan="1">15</td>
<td align="center" rowspan="1" colspan="1">.0009</td>
</tr>
<tr>
<td rowspan="1" colspan="1">Severe ototoxicity (9,000-16,000 Hz), %</td>
<td align="center" rowspan="1" colspan="1">80</td>
<td align="center" rowspan="1" colspan="1">35</td>
<td align="center" rowspan="1" colspan="1">.0027</td>
</tr>
<tr>
<td rowspan="1" colspan="1">Average threshold shift (4,000-8,000 Hz), LS mean dB</td>
<td align="center" rowspan="1" colspan="1">30.22</td>
<td align="center" rowspan="1" colspan="1">7.99</td>
<td align="center" rowspan="1" colspan="1">&lt;.0001</td>
</tr>
<tr>
<td rowspan="1" colspan="1">Average threshold shift (9,000-16,000 Hz), LS mean dB</td>
<td align="center" rowspan="1" colspan="1">21.38</td>
<td align="center" rowspan="1" colspan="1">9.19</td>
<td align="center" rowspan="1" colspan="1">.0022</td>
</tr>
<tr>
<td rowspan="1" colspan="1">Speech intelligibility index, LS mean</td>
<td align="center" rowspan="1" colspan="1">–0.15</td>
<td align="center" rowspan="1" colspan="1">–0.03</td>
<td align="center" rowspan="1" colspan="1">.0001</td>
</tr>
</tbody>
</table></div>
<div class="p text-right font-secondary"><a href="table/tbl3/" class="usa-link" target="_blank" rel="noopener noreferrer">Open in a new tab</a></div>
<div class="tw-foot p">
<div class="fn" id="fn4"><p>NOTE. <em>P</em> values were determined using chi-square analysis.</p></div>
<div class="fn" id="fn5"><p>Abbreviations: LOCF, last observation carried forward; LS, least squares.</p></div>
</div></section><figure class="fig xbox font-sm" id="fig3"><h4 class="obj_head">FIG 3.</h4>
<p class="img-box line-height-none margin-x-neg-2 tablet:margin-x-0 text-center"><a class="tileshop" target="_blank" href="https://www.ncbi.nlm.nih.gov/core/lw/2.0/html/tileshop_pmc/tileshop_pmc_inline.html?title=Click%20on%20image%20to%20zoom&amp;p=PMC3&amp;id=12199801_jco-43-2155-g003.jpg"><img class="graphic zoom-in" src="https://cdn.ncbi.nlm.nih.gov/pmc/blobs/52b1/12199801/5859a52a574b/jco-43-2155-g003.jpg" loading="lazy" height="1868" width="791" alt="FIG 3."></a></p>
<div class="p text-right font-secondary"><a href="figure/fig3/" class="usa-link" target="_blank" rel="noopener noreferrer">Open in a new tab</a></div>
<figcaption><p>Mean audiogram plot for (A) placebo, (B) DB-020 12%, and (C) DB-020 25%. Mean hearing levels at baseline and LOCF for frequencies of 250-16,000 Hz. LOCF, last observation carried forward.</p></figcaption></figure><p>The reduction in ototoxicity in DB-020–treated ears was also evident in the results from additional average threshold shift in air conduction and SII results. These effects were dose-responsive (Data Supplement, Tables S7-S9).</p>
<p>Results from DPOAEs, WIN, tympanometry, bone conduction threshold shifts, and HHIA assessments support the efficacy of DB-020 treatment for patients receiving high-dose cisplatin chemotherapy. A shift from DPOAEs being present to absent was generally more common in placebo-treated ears than in DB-020–treated ears, suggesting that DB-020 was effective in preserving hearing (Data Supplement, Table S10). Changes from baseline in WIN threshold results were greatest on placebo, lower on DB-020 12.5%, and lowest on DB-020 25% at 2.83, 2.22, and –0.28 dB, respectively (Data Supplement, Table S11). Tympanometry results indicated little-to-no middle ear function change after the IT injection. Only one ear each for placebo, DB-020 12.5%, and DB-020 25% shifted from category A (normal middle ear function) to C (eustachian tube dysfunction, or early or resolving middle ear infection; Data Supplement, Table S12). Bone conduction threshold shifts mirrored the air conduction changes (Data Supplement, Table S13). HHIA score results showed little change (Data Supplement, Table S14).</p></section></section><section id="sec17"><h2 class="pmc_sec_title">DISCUSSION</h2>
<p>Cisplatin ototoxicity was very common in placebo-treated ears and often severe, indicating a significant unmet need because of cisplatin-induced hearing loss. Ototoxicity was evident with the first cisplatin cycle and progressed over time, indicating the importance of treating the ear before every cisplatin administration.</p>
<p>Ototoxicity was reduced in DB-020–treated ears compared with placebo-treated ears. The difference was shown by a clear separation between ears for both the 250-8,000 Hz and 9,000-16,000 Hz frequency ranges at LOCF, respectively. There was clear evidence of a dose response.</p>
<p>Even after cycle 1, patterns of ototoxicity were similar to those at EOT. The reduction in ototoxicity with DB-020 treatment was clinically meaningful, determined according to relevant thresholds prospectively defined by the ASHA, and a difference was evident in speech reception on the WIN test. The consistency across ototoxicity assessments, the dose-dependent responses, and the large effect size provide robust evidence that DB-020 IT treatment reduced cisplatin ototoxicity. In line with results from recent studies,<sup><a href="#b6" class="usa-link" aria-describedby="b6">6</a></sup> these encouraging results provide further insight into cisplatin-related ototoxicity and suggest that DB-020 could be an alternative treatment option for patients receiving cisplatin-based chemotherapy.</p>
<p>In all but one case, the ear(s) affected by tinnitus were specified, allowing a comparison of placebo and DB-020. This showed that tinnitus was more common in placebo-treated ears than in DB-020–treated ears, suggesting tinnitus was related to ototoxicity.</p>
<p>HHIA assessments showed that a new handicap affected only one patient. Because this is a whole-person measure rather than an individual ear assessment, it is possible that preservation of hearing in only one ear with DB-020 avoided the development of a worsening handicap.</p>
<p>Administration of thiosulfate in the clinical setting requires close coordination between the otolaryngologist and the oncology team. In this study, administration logistics were feasible at multiple study sites, and all IT injections except one were administered within 3 hours of cisplatin chemotherapy.</p>
<p>A strength of this study was that each patient was their own control with one ear treated with DB-020 and the other with placebo. This enabled a clear treatment effect to become evident with a small sample size. Multiple assessments per patient and analyses across different frequencies also contributed to the robustness of the results (Data Supplement, Tables S4 and S6-S9). However, this design limited the extent to which some efficacy, particularly for the HHIA assessments, and safety data could be interpreted, as no patients received placebo in both ears.</p>
<p>Safety results indicated that DB-020 IT injections were well tolerated. The 14 SAEs were all determined to be unrelated to study drug, with nine occurring in DB-020 12%-treated patients and five in DB-020 25%-treated patients. Although ear pain was the most common TEAE related to DB-020 and IT injection, leading to the withdrawal of two patients, ear pain associated with IT injection resolved quickly (within approximately 10 minutes post injection). Overall, the safety profile was generally acceptable to patients who are otherwise faced with a very-high incidence of permanent hearing loss and risk of tinnitus.</p>
<p>Thiosulfate is a well-known and relatively safe treatment, and the observed safety profile in this study was entirely consistent with the safety profile of cisplatin and radiation. Although previous studies have shown thiosulfate to provide moderate hearing protection, the systemic administration methods that were used required a high intravenous thiosulfate dose (16 g/m<sup>2</sup> or 20 g/m<sup>2</sup>), resulting in high systemic levels of thiosulfate.<sup><a href="#b7" class="usa-link" aria-describedby="b7">7</a>,<a href="#b9" class="usa-link" aria-describedby="b9">9</a></sup> In this study, fifteen minutes before cisplatin administration, plasma concentrations of thiosulfate were below those that would be expected to affect cisplatin antitumor efficacy on the basis of nonclinical in vitro tumor cell antiproliferation studies.<sup><a href="#b17" class="usa-link" aria-describedby="b17">17</a></sup> These concentrations (≤530 ng/mL) were significantly lower than concentrations seen with systemic administration (approximately 2 million ng/mL).<sup><a href="#b1" class="usa-link" aria-describedby="b1">1</a></sup> Additionally, free cisplatin levels in this study were consistent with values expected in the absence of a cisplatin-chelating agent,<sup><a href="#b18" class="usa-link" aria-describedby="b18">18</a>,<a href="#b19" class="usa-link" aria-describedby="b19">19</a></sup> suggesting that DB-020 had no systemic impact on free cisplatin plasma concentrations. These results highlight the advantages of IT sodium thiosulfate injection, which only chelates cisplatin in the ear, leaving cisplatin free in other tissues for systemic antitumor effects.</p>
<p>In conclusion, overall, this clinical trial with DB-020 IT injections showed clear and meaningful reductions in cisplatin ototoxicity, low plasma concentration of thiosulfate, no apparent impact on plasma concentrations of free cisplatin, and a safety profile that supports continued development of the highest dose, DB-020 25%.</p></section><section id="ack1" class="ack"><h2 class="pmc_sec_title">ACKNOWLEDGMENT</h2>
<p>Editorial support was provided by Alpha (a division of Prime, Knutsford, United Kingdom), supported by Regeneron Pharmaceuticals, Inc.</p></section><section id="notes1"><section id="fn-group5" class="fn-group"><div class="fn-group p font-secondary-light font-sm">
<div class="fn p" id="fn22">
<p>
<strong>Benedict J. Panizza</strong>
</p>
<p><strong>Stock and Other Ownership Interests:</strong> Cochlear Ltd, Ramsay Health Care, Sonic Healthcare</p>
<p><strong>Speakers' Bureau:</strong> Sanofi-Aventis Australia Pty Ltd</p>
<p><strong>Research Funding:</strong> Decibel Therapeutics (Inst), QBiotics (Inst)</p>
</div>
<div class="fn p" id="fn23">
<p>
<strong>Stephen O'Leary</strong>
</p>
<p><strong>Honoraria:</strong> Cochlear Ltd</p>
<p><strong>Speakers' Bureau:</strong> Cochlear Ltd, Sensorion</p>
<p><strong>Research Funding:</strong> Cochlear Ltd (Inst)</p>
<p><strong>Patents, Royalties, Other Intellectual Property:</strong> Named inventor on patents arising from my work at the University of Melbourne arising from research grants to the Institution from Cochlear. None are delivering royalties (Inst)</p>
</div>
<div class="fn p" id="fn24">
<p>
<strong>Chandra Sai Diwakarla</strong>
</p>
<p><strong>Travel, Accommodations, Expenses:</strong> Novartis</p>
</div>
<div class="fn p" id="fn25">
<p>
<strong>Pablo Lapuerta</strong>
</p>
<p><strong>Employment:</strong> 4M Therapeutics Inc (I)</p>
<p><strong>Leadership:</strong> 4M Therapeutics Inc</p>
<p><strong>Stock and Other Ownership Interests:</strong> 4M Therapeutics Inc, 4M Therapeutics Inc (I), Lexicon, Sarepta Therapeutics, Pelagos, Youngene Therapeutics, EncuraGen</p>
<p><strong>Consulting or Advisory Role:</strong> Pelagos, EncuraGen, Youngene Therapeutics, Regeneron, Decibel Therapeutics</p>
<p><strong>Travel, Accommodations, Expenses:</strong> Regeneron, Decibel Therapeutics, Youngene Therapeutics</p>
</div>
<div class="fn p" id="fn26">
<p>
<strong>John Lee</strong>
</p>
<p><strong>Employment:</strong> Decibel Therapeutics, Regeneron</p>
<p><strong>Leadership:</strong> Decibel Therapeutics</p>
<p><strong>Stock and Other Ownership Interests:</strong> Decibel Therapeutics</p>
<p><strong>Consulting or Advisory Role:</strong> Source Bio, Matrisome Bio</p>
<p><strong>Research Funding:</strong> Decibel Therapeutics, Regeneron</p>
<p><strong>Patents, Royalties, Other Intellectual Property:</strong> Patents from work at Decibel Therapeutics associated with work on delivery, formulation, and programs, including DB-020</p>
<p><strong>Travel, Accommodations, Expenses:</strong> Decibel Therapeutics, Regeneron</p>
</div>
<div class="fn p" id="fn27">
<p>
<strong>Shane Raines</strong>
</p>
<p><strong>Consulting or Advisory Role:</strong> Decibel Therapeutics (Inst)</p>
</div>
<div class="fn p" id="fn28">
<p>
<strong>Tera Quigley</strong>
</p>
<p><strong>Employment:</strong> Regeneron, Decibel Therapeutics</p>
<p><strong>Stock and Other Ownership Interests:</strong> Regeneron, Decibel Therapeutics</p>
<p><strong>Travel, Accommodations, Expenses:</strong> Regeneron, Decibel Therapeutics</p>
</div>
<div class="fn p" id="fn29">
<p>
<strong>John Keilty</strong>
</p>
<p><strong>Stock and Other Ownership Interests:</strong> Pfizer, Amgen, Thermo Fisher Scientific, MOMA Therapeutics</p>
</div>
<div class="fn p" id="fn30">
<p>
<strong>Rahul Ladwa</strong>
</p>
<p><strong>Honoraria:</strong> MSD (Inst), Sanofi (Inst)</p>
<p><strong>Consulting or Advisory Role:</strong> Merck Sharp &amp; Dohme (Inst), La Roche-Posay (Inst)</p>
<p><strong>Research Funding:</strong> MSD</p>
<p><strong>Travel, Accommodations, Expenses:</strong> Sanofi, MSD</p>
</div>
<div class="fn p" id="fn31">
<p>
<strong>Sandro V. Porceddu</strong>
</p>
<p><strong>Stock and Other Ownership Interests:</strong> Icon Cancer Care (I)</p>
<p><strong>Consulting or Advisory Role:</strong> Regeneron</p>
<p><strong>Patents, Royalties, Other Intellectual Property:</strong> UpToDate Royalties as Chapter author</p>
<p><strong>Travel, Accommodations, Expenses:</strong> Merck Serono, Merck Sharp &amp; Dohme</p>
</div>
<div class="fn p" id="fn32">
<p>
<strong>Margaret McGrath</strong>
</p>
<p><strong>Honoraria:</strong> Medison</p>
<p><strong>Consulting or Advisory Role:</strong> Medison</p>
<p><strong>Speakers' Bureau:</strong> La Roche-Posay</p>
<p><strong>Travel, Accommodations, Expenses:</strong> MSD</p>
</div>
<div class="fn p" id="fn33">
<p>
<strong>Nagashree Seetharamu</strong>
</p>
<p><strong>Honoraria:</strong> AstraZeneca/MedImmune, Pfizer, Janssen Oncology, Mirati Therapeutics, Blueprint Medicines, Takeda, Boehringer Ingelheim, Amgen, Genentech, Array BioPharma, Jazz Pharmaceuticals</p>
<p><strong>Consulting or Advisory Role:</strong> AstraZeneca, Genentech, Takeda, Amgen, Boehringer Ingelheim, Mirati Therapeutics, Blueprint Medicines, Regeneron</p>
<p><strong>Other Relationship:</strong> Regeneron</p>
</div>
<div class="fn p" id="fn34">
<p>
<strong>Danny Rischin</strong>
</p>
<p><strong>Research Funding:</strong> Merck (Inst), Regeneron (Inst), Decibel Therapeutics (Inst), ALX Oncology (Inst), AstraZeneca (Inst), Erasca, Inc (Inst), Bicara Therapeutics (Inst)</p>
<p><strong>Uncompensated Relationships:</strong> Regeneron, Merck, GlaxoSmithKline, Eisai</p>
<p>No other potential conflicts of interest were reported.</p>
</div>
</div></section></section><section id="fn-group1" class="fn-group"><div class="fn-group p font-secondary-light font-sm"><div class="fn p" id="fn6"><p>See accompanying Editorial, p. <a href="https://doi.org/10.1200/JCO-25-00548" class="usa-link usa-link--external" data-ga-action="click_feat_suppl" target="_blank" rel="noopener noreferrer">2139</a></p></div></div></section><section id="fn-group2" class="fn-group"><h2 class="pmc_sec_title">PRIOR PRESENTATION</h2>
<div class="fn-group p font-secondary-light font-sm"><div class="fn p" id="fn7"><p>Presented in part at ASCO 2023, Chicago, IL, June 2-6, 2023; and in full at ASCO 2024, Chicago, IL, May 31-June 4, 2024.</p></div></div></section><section id="fn-group3" class="fn-group"><h2 class="pmc_sec_title">SUPPORT</h2>
<div class="fn-group p font-secondary-light font-sm"><div class="fn p" id="fn8"><p>Supported by Decibel Therapeutics Inc.</p></div></div></section><section id="sec18"><h2 class="pmc_sec_title">DATA SHARING STATEMENT</h2>
<p>A data sharing statement provided by the authors is available with this article at DOI <a href="https://ascopubs.org/doi/full/10.1200/JCO.24.00905" class="usa-link usa-link--external" data-ga-action="click_feat_suppl" target="_blank" rel="noopener noreferrer">https://doi.org/10.1200/JCO.24.00905</a>.</p></section><section id="sec19"><h2 class="pmc_sec_title">AUTHOR CONTRIBUTIONS</h2>
<p><strong>Conception and design:</strong> Benedict J. Panizza, Pablo Lapuerta, John Lee, Shane Raines, Heather M Wolff, John Keilty, Danny Rischin</p>
<p><strong>Financial support:</strong> John Lee</p>
<p><strong>Provision of study materials or patients:</strong> Benedict J. Panizza, Christopher David Hart, Chandra Sai Diwakarla, Catherine Barnett, Pablo Lapuerta, John Lee, Sandro V. Porceddu, Margaret McGrath, Nagashree Seetharamu, Danny Rischin</p>
<p><strong>Collection and assembly of data:</strong> Benedict J. Panizza, Stephen John O'Leary, Christopher David Hart, Catherine Barnett, Pablo Lapuerta, Shane Raines, Tera Quigley, Heather M. Wolff, John Keilty, Rahul Ladwa, Sandro V. Porceddu, Margaret McGrath, Nagashree Seetharamu, Danny Rischin</p>
<p><strong>Data analysis and interpretation:</strong> Benedict J. Panizza, Stephen John O'Leary, Chandra Sai Diwakarla, Catherine Barnett, Pablo Lapuerta, John Lee, Shane Raines, Tera Quigley, Heather M. Wolff, John Keilty, Rahul Ladwa, Sandro V. Porceddu, Nagashree Seetharamu, Tsien Fua, Danny Rischin</p>
<p><strong>Manuscript writing:</strong> All authors</p>
<p><strong>Final approval of manuscript:</strong> All authors</p>
<p><strong>Accountable for all aspects of the work:</strong> All authors</p></section><section id="sec20"><h2 class="pmc_sec_title">AUTHORS' DISCLOSURES OF POTENTIAL CONFLICTS OF INTEREST</h2>
<section id="sec21"><h3 class="pmc_sec_title">Randomized Phase Ib Clinical Trial of DB-020 Intratympanic Injections to Reduce High-Dose Cisplatin Ototoxicity</h3>
<p>The following represents disclosure information provided by authors of this manuscript. All relationships are considered compensated unless otherwise noted. Relationships are self-held unless noted. I = Immediate Family Member, Inst = My Institution. Relationships may not relate to the subject matter of this manuscript. For more information about ASCO's conflict of interest policy, please refer to <a href="http://www.asco.org/rwc" class="usa-link usa-link--external" data-ga-action="click_feat_suppl" target="_blank" rel="noopener noreferrer">www.asco.org/rwc</a> or <a href="https://ascopubs.org/jco/authors/author-center" class="usa-link usa-link--external" data-ga-action="click_feat_suppl" target="_blank" rel="noopener noreferrer">ascopubs.org/jco/authors/author-center</a>.</p>
<p>Open Payments is a public database containing information reported by companies about payments made to US-licensed physicians (<a href="https://openpaymentsdata.cms.gov/" class="usa-link usa-link--external" data-ga-action="click_feat_suppl" target="_blank" rel="noopener noreferrer">Open Payments</a>).</p>
<section id="fn-group4" class="fn-group"><div class="fn-group p font-secondary-light font-sm">
<div class="fn p" id="con1">
<p>
<strong>Benedict J. Panizza</strong>
</p>
<p><strong>Stock and Other Ownership Interests:</strong> Cochlear Ltd, Ramsay Health Care, Sonic Healthcare</p>
<p><strong>Speakers' Bureau:</strong> Sanofi-Aventis Australia Pty Ltd</p>
<p><strong>Research Funding:</strong> Decibel Therapeutics (Inst), QBiotics (Inst)</p>
</div>
<div class="fn p" id="con2">
<p>
<strong>Stephen O'Leary</strong>
</p>
<p><strong>Honoraria:</strong> Cochlear Ltd</p>
<p><strong>Speakers' Bureau:</strong> Cochlear Ltd, Sensorion</p>
<p><strong>Research Funding:</strong> Cochlear Ltd (Inst)</p>
<p><strong>Patents, Royalties, Other Intellectual Property:</strong> Named inventor on patents arising from my work at the University of Melbourne arising from research grants to the Institution from Cochlear. None are delivering royalties (Inst)</p>
</div>
<div class="fn p" id="con3">
<p>
<strong>Chandra Sai Diwakarla</strong>
</p>
<p><strong>Travel, Accommodations, Expenses:</strong> Novartis</p>
</div>
<div class="fn p" id="con4">
<p>
<strong>Pablo Lapuerta</strong>
</p>
<p><strong>Employment:</strong> 4M Therapeutics Inc (I)</p>
<p><strong>Leadership:</strong> 4M Therapeutics Inc</p>
<p><strong>Stock and Other Ownership Interests:</strong> 4M Therapeutics Inc, 4M Therapeutics Inc (I), Lexicon, Sarepta Therapeutics, Pelagos, Youngene Therapeutics, EncuraGen</p>
<p><strong>Consulting or Advisory Role:</strong> Pelagos, EncuraGen, Youngene Therapeutics, Regeneron, Decibel Therapeutics</p>
<p><strong>Travel, Accommodations, Expenses:</strong> Regeneron, Decibel Therapeutics, Youngene Therapeutics</p>
</div>
<div class="fn p" id="con5">
<p>
<strong>John Lee</strong>
</p>
<p><strong>Employment:</strong> Decibel Therapeutics, Regeneron</p>
<p><strong>Leadership:</strong> Decibel Therapeutics</p>
<p><strong>Stock and Other Ownership Interests:</strong> Decibel Therapeutics</p>
<p><strong>Consulting or Advisory Role:</strong> Source Bio, Matrisome Bio</p>
<p><strong>Research Funding:</strong> Decibel Therapeutics, Regeneron</p>
<p><strong>Patents, Royalties, Other Intellectual Property:</strong> Patents from work at Decibel Therapeutics associated with work on delivery, formulation, and programs, including DB-020</p>
<p><strong>Travel, Accommodations, Expenses:</strong> Decibel Therapeutics, Regeneron</p>
</div>
<div class="fn p" id="con6">
<p>
<strong>Shane Raines</strong>
</p>
<p><strong>Consulting or Advisory Role:</strong> Decibel Therapeutics (Inst)</p>
</div>
<div class="fn p" id="con7">
<p>
<strong>Tera Quigley</strong>
</p>
<p><strong>Employment:</strong> Regeneron, Decibel Therapeutics</p>
<p><strong>Stock and Other Ownership Interests:</strong> Regeneron, Decibel Therapeutics</p>
<p><strong>Travel, Accommodations, Expenses:</strong> Regeneron, Decibel Therapeutics</p>
</div>
<div class="fn p" id="con8">
<p>
<strong>John Keilty</strong>
</p>
<p><strong>Stock and Other Ownership Interests:</strong> Pfizer, Amgen, Thermo Fisher Scientific, MOMA Therapeutics</p>
</div>
<div class="fn p" id="con9">
<p>
<strong>Rahul Ladwa</strong>
</p>
<p><strong>Honoraria:</strong> MSD (Inst), Sanofi (Inst)</p>
<p><strong>Consulting or Advisory Role:</strong> Merck Sharp &amp; Dohme (Inst), La Roche-Posay (Inst)</p>
<p><strong>Research Funding:</strong> MSD</p>
<p><strong>Travel, Accommodations, Expenses:</strong> Sanofi, MSD</p>
</div>
<div class="fn p" id="con10">
<p>
<strong>Sandro V. Porceddu</strong>
</p>
<p><strong>Stock and Other Ownership Interests:</strong> Icon Cancer Care (I)</p>
<p><strong>Consulting or Advisory Role:</strong> Regeneron</p>
<p><strong>Patents, Royalties, Other Intellectual Property:</strong> UpToDate Royalties as Chapter author</p>
<p><strong>Travel, Accommodations, Expenses:</strong> Merck Serono, Merck Sharp &amp; Dohme</p>
</div>
<div class="fn p" id="con11">
<p>
<strong>Margaret McGrath</strong>
</p>
<p><strong>Honoraria:</strong> Medison</p>
<p><strong>Consulting or Advisory Role:</strong> Medison</p>
<p><strong>Speakers' Bureau:</strong> La Roche-Posay</p>
<p><strong>Travel, Accommodations, Expenses:</strong> MSD</p>
</div>
<div class="fn p" id="con12">
<p>
<strong>Nagashree Seetharamu</strong>
</p>
<p><strong>Honoraria:</strong> AstraZeneca/MedImmune, Pfizer, Janssen Oncology, Mirati Therapeutics, Blueprint Medicines, Takeda, Boehringer Ingelheim, Amgen, Genentech, Array BioPharma, Jazz Pharmaceuticals</p>
<p><strong>Consulting or Advisory Role:</strong> AstraZeneca, Genentech, Takeda, Amgen, Boehringer Ingelheim, Mirati Therapeutics, Blueprint Medicines, Regeneron</p>
<p><strong>Other Relationship:</strong> Regeneron</p>
</div>
<div class="fn p" id="con13">
<p>
<strong>Danny Rischin</strong>
</p>
<p><strong>Research Funding:</strong> Merck (Inst), Regeneron (Inst), Decibel Therapeutics (Inst), ALX Oncology (Inst), AstraZeneca (Inst), Erasca, Inc (Inst), Bicara Therapeutics (Inst)</p>
<p><strong>Uncompensated Relationships:</strong> Regeneron, Merck, GlaxoSmithKline, Eisai</p>
<p>No other potential conflicts of interest were reported.</p>
</div>
</div></section></section></section><section id="ref-list1" class="ref-list"><h2 class="pmc_sec_title">REFERENCES</h2>
<section id="ref-list1_sec2"><ul class="ref-list font-sm" style="list-style-type:none">
<li id="b1">
<span class="label">1.</span><cite>
Viglietta V, Shi F, Hu QY, et al. 
Phase 1 study to evaluate safety, tolerability and pharmacokinetics of a novel intra-tympanic administered thiosulfate to prevent cisplatin-induced hearing loss in cancer patients. 






Invest New Drugs. 2020;38:1463–1471. doi: 10.1007/s10637-020-00918-1.</cite> [<a href="https://doi.org/10.1007/s10637-020-00918-1" class="usa-link usa-link--external" data-ga-action="click_feat_suppl" target="_blank" rel="noopener noreferrer">DOI</a>] [<a href="/articles/PMC7497691/" class="usa-link">PMC free article</a>] [<a href="https://pubmed.ncbi.nlm.nih.gov/32157599/" class="usa-link">PubMed</a>] [<a href="https://scholar.google.com/scholar_lookup?journal=Invest%20New%20Drugs&amp;title=Phase%201%20study%20to%20evaluate%20safety,%20tolerability%20and%20pharmacokinetics%20of%20a%20novel%20intra-tympanic%20administered%20thiosulfate%20to%20prevent%20cisplatin-induced%20hearing%20loss%20in%20cancer%20patients&amp;author=V%20Viglietta&amp;author=F%20Shi&amp;author=QY%20Hu&amp;volume=38&amp;publication_year=2020&amp;pages=1463-1471&amp;pmid=32157599&amp;doi=10.1007/s10637-020-00918-1&amp;" class="usa-link usa-link--external" data-ga-action="click_feat_suppl" target="_blank" rel="noopener noreferrer">Google Scholar</a>]</li>
<li id="b2">
<span class="label">2.</span><cite>
Hamid M, Trune D.
Issues, indications, and controversies regarding intratympanic steroid perfusion. 






Curr Opin Otolaryngol Head Neck Surg. 2008;16:434–440. doi: 10.1097/MOO.0b013e32830ce796.</cite> [<a href="https://doi.org/10.1097/MOO.0b013e32830ce796" class="usa-link usa-link--external" data-ga-action="click_feat_suppl" target="_blank" rel="noopener noreferrer">DOI</a>] [<a href="/articles/PMC2664082/" class="usa-link">PMC free article</a>] [<a href="https://pubmed.ncbi.nlm.nih.gov/18797285/" class="usa-link">PubMed</a>] [<a href="https://scholar.google.com/scholar_lookup?journal=Curr%20Opin%20Otolaryngol%20Head%20Neck%20Surg&amp;title=Issues,%20indications,%20and%20controversies%20regarding%20intratympanic%20steroid%20perfusion&amp;author=M%20Hamid&amp;author=D%20Trune&amp;volume=16&amp;publication_year=2008&amp;pages=434-440&amp;pmid=18797285&amp;doi=10.1097/MOO.0b013e32830ce796&amp;" class="usa-link usa-link--external" data-ga-action="click_feat_suppl" target="_blank" rel="noopener noreferrer">Google Scholar</a>]</li>
<li id="b3">
<span class="label">3.</span><cite>
Paken J, Govender CD, Pillay M, et al. 
Cisplatin-associated ototoxicity: A review for the Health professional. 





J Toxicol. 2016;2016:1809394. doi: 10.1155/2016/1809394.</cite> [<a href="https://doi.org/10.1155/2016/1809394" class="usa-link usa-link--external" data-ga-action="click_feat_suppl" target="_blank" rel="noopener noreferrer">DOI</a>] [<a href="/articles/PMC5223030/" class="usa-link">PMC free article</a>] [<a href="https://pubmed.ncbi.nlm.nih.gov/28115933/" class="usa-link">PubMed</a>] [<a href="https://scholar.google.com/scholar_lookup?journal=J%20Toxicol&amp;title=Cisplatin-associated%20ototoxicity:%20A%20review%20for%20the%20Health%20professional&amp;author=J%20Paken&amp;author=CD%20Govender&amp;author=M%20Pillay&amp;volume=2016&amp;publication_year=2016&amp;pages=1809394&amp;pmid=28115933&amp;doi=10.1155/2016/1809394&amp;" class="usa-link usa-link--external" data-ga-action="click_feat_suppl" target="_blank" rel="noopener noreferrer">Google Scholar</a>]</li>
<li id="b4">
<span class="label">4.</span><cite>
Karasawa T, Sibrian-Vazquez M, Strongin RM, et al. 
Identification of cisplatin-binding proteins using agarose conjugates of platinum compounds. 





PLoS One. 2013;8:e66220. doi: 10.1371/journal.pone.0066220.</cite> [<a href="https://doi.org/10.1371/journal.pone.0066220" class="usa-link usa-link--external" data-ga-action="click_feat_suppl" target="_blank" rel="noopener noreferrer">DOI</a>] [<a href="/articles/PMC3670892/" class="usa-link">PMC free article</a>] [<a href="https://pubmed.ncbi.nlm.nih.gov/23755301/" class="usa-link">PubMed</a>] [<a href="https://scholar.google.com/scholar_lookup?journal=PLoS%20One&amp;title=Identification%20of%20cisplatin-binding%20proteins%20using%20agarose%20conjugates%20of%20platinum%20compounds&amp;author=T%20Karasawa&amp;author=M%20Sibrian-Vazquez&amp;author=RM%20Strongin&amp;volume=8&amp;publication_year=2013&amp;pages=e66220&amp;pmid=23755301&amp;doi=10.1371/journal.pone.0066220&amp;" class="usa-link usa-link--external" data-ga-action="click_feat_suppl" target="_blank" rel="noopener noreferrer">Google Scholar</a>]</li>
<li id="b5">
<span class="label">5.</span><cite>
Chattaraj A, Syed MP, Low CA, et al. 
Cisplatin-induced ototoxicity: A concise review of the burden, prevention, and interception strategies. 






JCO Oncol Pract. 2023;19:278–283. doi: 10.1200/OP.22.00710.</cite> [<a href="https://doi.org/10.1200/OP.22.00710" class="usa-link usa-link--external" data-ga-action="click_feat_suppl" target="_blank" rel="noopener noreferrer">DOI</a>] [<a href="/articles/PMC10414722/" class="usa-link">PMC free article</a>] [<a href="https://pubmed.ncbi.nlm.nih.gov/36921239/" class="usa-link">PubMed</a>] [<a href="https://scholar.google.com/scholar_lookup?journal=JCO%20Oncol%20Pract&amp;title=Cisplatin-induced%20ototoxicity:%20A%20concise%20review%20of%20the%20burden,%20prevention,%20and%20interception%20strategies&amp;author=A%20Chattaraj&amp;author=MP%20Syed&amp;author=CA%20Low&amp;volume=19&amp;publication_year=2023&amp;pages=278-283&amp;pmid=36921239&amp;doi=10.1200/OP.22.00710&amp;" class="usa-link usa-link--external" data-ga-action="click_feat_suppl" target="_blank" rel="noopener noreferrer">Google Scholar</a>]</li>
<li id="b6">
<span class="label">6.</span><cite>
Taş BM, Şimşek G, Azman M, et al. 
Efficacy of 2 different intratympanic steroid regimen on prevention of cisplatin ototoxicity: An experimental study. 






Ear Nose Throat J. 2021;100:417–422. doi: 10.1177/0145561319874311.</cite> [<a href="https://doi.org/10.1177/0145561319874311" class="usa-link usa-link--external" data-ga-action="click_feat_suppl" target="_blank" rel="noopener noreferrer">DOI</a>] [<a href="https://pubmed.ncbi.nlm.nih.gov/31569969/" class="usa-link">PubMed</a>] [<a href="https://scholar.google.com/scholar_lookup?journal=Ear%20Nose%20Throat%20J&amp;title=Efficacy%20of%202%20different%20intratympanic%20steroid%20regimen%20on%20prevention%20of%20cisplatin%20ototoxicity:%20An%20experimental%20study&amp;author=BM%20Ta%C5%9F&amp;author=G%20%C5%9Eim%C5%9Fek&amp;author=M%20Azman&amp;volume=100&amp;publication_year=2021&amp;pages=417-422&amp;pmid=31569969&amp;doi=10.1177/0145561319874311&amp;" class="usa-link usa-link--external" data-ga-action="click_feat_suppl" target="_blank" rel="noopener noreferrer">Google Scholar</a>]</li>
<li id="b7">
<span class="label">7.</span><cite>
Brock PR, Maibach R, Childs M, et al. 
Sodium thiosulfate for protection from cisplatin-induced hearing loss. 






N Engl J Med. 2018;378:2376–2385. doi: 10.1056/NEJMoa1801109.</cite> [<a href="https://doi.org/10.1056/NEJMoa1801109" class="usa-link usa-link--external" data-ga-action="click_feat_suppl" target="_blank" rel="noopener noreferrer">DOI</a>] [<a href="/articles/PMC6117111/" class="usa-link">PMC free article</a>] [<a href="https://pubmed.ncbi.nlm.nih.gov/29924955/" class="usa-link">PubMed</a>] [<a href="https://scholar.google.com/scholar_lookup?journal=N%20Engl%20J%20Med&amp;title=Sodium%20thiosulfate%20for%20protection%20from%20cisplatin-induced%20hearing%20loss&amp;author=PR%20Brock&amp;author=R%20Maibach&amp;author=M%20Childs&amp;volume=378&amp;publication_year=2018&amp;pages=2376-2385&amp;pmid=29924955&amp;doi=10.1056/NEJMoa1801109&amp;" class="usa-link usa-link--external" data-ga-action="click_feat_suppl" target="_blank" rel="noopener noreferrer">Google Scholar</a>]</li>
<li id="b8">
<span class="label">8.</span><cite>
Dhillon S.
Sodium thiosulfate: Pediatric first approval. 






Paediatr Drugs. 2023;25:239–244. doi: 10.1007/s40272-022-00550-x.</cite> [<a href="https://doi.org/10.1007/s40272-022-00550-x" class="usa-link usa-link--external" data-ga-action="click_feat_suppl" target="_blank" rel="noopener noreferrer">DOI</a>] [<a href="https://pubmed.ncbi.nlm.nih.gov/36517667/" class="usa-link">PubMed</a>] [<a href="https://scholar.google.com/scholar_lookup?journal=Paediatr%20Drugs&amp;title=Sodium%20thiosulfate:%20Pediatric%20first%20approval&amp;author=S%20Dhillon&amp;volume=25&amp;publication_year=2023&amp;pages=239-244&amp;pmid=36517667&amp;doi=10.1007/s40272-022-00550-x&amp;" class="usa-link usa-link--external" data-ga-action="click_feat_suppl" target="_blank" rel="noopener noreferrer">Google Scholar</a>]</li>
<li id="b9">
<span class="label">9.</span><cite>
Freyer DR, Chen L, Krailo MD, et al. 
Effects of sodium thiosulfate versus observation on development of cisplatin-induced hearing loss in children with cancer (ACCL0431): A multicentre, randomised, controlled, open-label, phase 3 trial. 






Lancet Oncol. 2017;18:63–74. doi: 10.1016/S1470-2045(16)30625-8.</cite> [<a href="https://doi.org/10.1016/S1470-2045(16)30625-8" class="usa-link usa-link--external" data-ga-action="click_feat_suppl" target="_blank" rel="noopener noreferrer">DOI</a>] [<a href="/articles/PMC5520988/" class="usa-link">PMC free article</a>] [<a href="https://pubmed.ncbi.nlm.nih.gov/27914822/" class="usa-link">PubMed</a>] [<a href="https://scholar.google.com/scholar_lookup?journal=Lancet%20Oncol&amp;title=Effects%20of%20sodium%20thiosulfate%20versus%20observation%20on%20development%20of%20cisplatin-induced%20hearing%20loss%20in%20children%20with%20cancer%20(ACCL0431):%20A%20multicentre,%20randomised,%20controlled,%20open-label,%20phase%203%20trial&amp;author=DR%20Freyer&amp;author=L%20Chen&amp;author=MD%20Krailo&amp;volume=18&amp;publication_year=2017&amp;pages=63-74&amp;pmid=27914822&amp;doi=10.1016/S1470-2045(16)30625-8&amp;" class="usa-link usa-link--external" data-ga-action="click_feat_suppl" target="_blank" rel="noopener noreferrer">Google Scholar</a>]</li>
<li id="b10">
<span class="label">10.</span><cite>American Speech-Language-Hearing Association Audiologic management of individuals receiving cochleotoxic drug therapy [Guidelines] 1994. <a href="http://www.asha.org/policy" class="usa-link usa-link--external" data-ga-action="click_feat_suppl" target="_blank" rel="noopener noreferrer">www.asha.org/policy</a></cite>
</li>
<li id="b11">
<span class="label">11.</span><cite>
Kates JM, Arehart KH.
Coherence and the speech intelligibility index. 






J Acoust Soc Am. 2005;117:2224–2237. doi: 10.1121/1.1862575.</cite> [<a href="https://doi.org/10.1121/1.1862575" class="usa-link usa-link--external" data-ga-action="click_feat_suppl" target="_blank" rel="noopener noreferrer">DOI</a>] [<a href="https://pubmed.ncbi.nlm.nih.gov/15898663/" class="usa-link">PubMed</a>] [<a href="https://scholar.google.com/scholar_lookup?journal=J%20Acoust%20Soc%20Am&amp;title=Coherence%20and%20the%20speech%20intelligibility%20index&amp;author=JM%20Kates&amp;author=KH%20Arehart&amp;volume=117&amp;publication_year=2005&amp;pages=2224-2237&amp;pmid=15898663&amp;doi=10.1121/1.1862575&amp;" class="usa-link usa-link--external" data-ga-action="click_feat_suppl" target="_blank" rel="noopener noreferrer">Google Scholar</a>]</li>
<li id="b12">
<span class="label">12.</span><cite>
Jedrzejczak WW, Pilka E, Ganc M, et al. 
Ultra-high frequency distortion product otoacoustic emissions for detection of hearing loss and tinnitus. 





Int J Environ Res Public Health. 2022;19:2123. doi: 10.3390/ijerph19042123.</cite> [<a href="https://doi.org/10.3390/ijerph19042123" class="usa-link usa-link--external" data-ga-action="click_feat_suppl" target="_blank" rel="noopener noreferrer">DOI</a>] [<a href="/articles/PMC8872281/" class="usa-link">PMC free article</a>] [<a href="https://pubmed.ncbi.nlm.nih.gov/35206311/" class="usa-link">PubMed</a>] [<a href="https://scholar.google.com/scholar_lookup?journal=Int%20J%20Environ%20Res%20Public%20Health&amp;title=Ultra-high%20frequency%20distortion%20product%20otoacoustic%20emissions%20for%20detection%20of%20hearing%20loss%20and%20tinnitus&amp;author=WW%20Jedrzejczak&amp;author=E%20Pilka&amp;author=M%20Ganc&amp;volume=19&amp;publication_year=2022&amp;pages=2123&amp;pmid=35206311&amp;doi=10.3390/ijerph19042123&amp;" class="usa-link usa-link--external" data-ga-action="click_feat_suppl" target="_blank" rel="noopener noreferrer">Google Scholar</a>]</li>
<li id="b13">
<span class="label">13.</span><cite>
Wilson RH.
Clinical experience with the words-in-noise test on 3430 veterans: Comparisons with pure-tone thresholds and word recognition in quiet. 






J Am Acad Audiol. 2011;22:405–423. doi: 10.3766/jaaa.22.7.3.</cite> [<a href="https://doi.org/10.3766/jaaa.22.7.3" class="usa-link usa-link--external" data-ga-action="click_feat_suppl" target="_blank" rel="noopener noreferrer">DOI</a>] [<a href="https://pubmed.ncbi.nlm.nih.gov/21993048/" class="usa-link">PubMed</a>] [<a href="https://scholar.google.com/scholar_lookup?journal=J%20Am%20Acad%20Audiol&amp;title=Clinical%20experience%20with%20the%20words-in-noise%20test%20on%203430%20veterans:%20Comparisons%20with%20pure-tone%20thresholds%20and%20word%20recognition%20in%20quiet&amp;author=RH%20Wilson&amp;volume=22&amp;publication_year=2011&amp;pages=405-423&amp;pmid=21993048&amp;doi=10.3766/jaaa.22.7.3&amp;" class="usa-link usa-link--external" data-ga-action="click_feat_suppl" target="_blank" rel="noopener noreferrer">Google Scholar</a>]</li>
<li id="b14">
<span class="label">14.</span><cite>
Lous J, Hansen JG, Felding JU.
[Tympanometry] 






Ugeskr Laeger. 2000;162:1908–1911.</cite> [<a href="https://pubmed.ncbi.nlm.nih.gov/10765708/" class="usa-link">PubMed</a>] [<a href="https://scholar.google.com/scholar_lookup?journal=Ugeskr%20Laeger&amp;title=%5BTympanometry%5D&amp;author=J%20Lous&amp;author=JG%20Hansen&amp;author=JU%20Felding&amp;volume=162&amp;publication_year=2000&amp;pages=1908-1911&amp;pmid=10765708&amp;" class="usa-link usa-link--external" data-ga-action="click_feat_suppl" target="_blank" rel="noopener noreferrer">Google Scholar</a>]</li>
<li id="b15">
<span class="label">15.</span><cite>
Newman CW, Weinstein BE, Jacobson GP, et al. 
The hearing handicap inventory for adults: Psychometric adequacy and audiometric correlates. 






Ear Hear. 1990;11:430–433. doi: 10.1097/00003446-199012000-00004.</cite> [<a href="https://doi.org/10.1097/00003446-199012000-00004" class="usa-link usa-link--external" data-ga-action="click_feat_suppl" target="_blank" rel="noopener noreferrer">DOI</a>] [<a href="https://pubmed.ncbi.nlm.nih.gov/2073976/" class="usa-link">PubMed</a>] [<a href="https://scholar.google.com/scholar_lookup?journal=Ear%20Hear&amp;title=The%20hearing%20handicap%20inventory%20for%20adults:%20Psychometric%20adequacy%20and%20audiometric%20correlates&amp;author=CW%20Newman&amp;author=BE%20Weinstein&amp;author=GP%20Jacobson&amp;volume=11&amp;publication_year=1990&amp;pages=430-433&amp;pmid=2073976&amp;doi=10.1097/00003446-199012000-00004&amp;" class="usa-link usa-link--external" data-ga-action="click_feat_suppl" target="_blank" rel="noopener noreferrer">Google Scholar</a>]</li>
<li id="b16">
<span class="label">16.</span><cite>
Oken MM, Creech RH, Tormey DC, et al. 
Toxicity and response criteria of the Eastern Cooperative Oncology Group. 






Am J Clin Oncol. 1982;5:649–655.</cite> [<a href="https://pubmed.ncbi.nlm.nih.gov/7165009/" class="usa-link">PubMed</a>] [<a href="https://scholar.google.com/scholar_lookup?journal=Am%20J%20Clin%20Oncol&amp;title=Toxicity%20and%20response%20criteria%20of%20the%20Eastern%20Cooperative%20Oncology%20Group&amp;author=MM%20Oken&amp;author=RH%20Creech&amp;author=DC%20Tormey&amp;volume=5&amp;publication_year=1982&amp;pages=649-655&amp;pmid=7165009&amp;" class="usa-link usa-link--external" data-ga-action="click_feat_suppl" target="_blank" rel="noopener noreferrer">Google Scholar</a>]</li>
<li id="b17">
<span class="label">17.</span><cite>
Berglin CE, Pierre PV, Bramer T, et al. 
Prevention of cisplatin-induced hearing loss by administration of a thiosulfate-containing gel to the middle ear in a Guinea pig model. 






Cancer Chemother Pharmacol. 2011;68:1547–1556. doi: 10.1007/s00280-011-1656-2.</cite> [<a href="https://doi.org/10.1007/s00280-011-1656-2" class="usa-link usa-link--external" data-ga-action="click_feat_suppl" target="_blank" rel="noopener noreferrer">DOI</a>] [<a href="https://pubmed.ncbi.nlm.nih.gov/21533919/" class="usa-link">PubMed</a>] [<a href="https://scholar.google.com/scholar_lookup?journal=Cancer%20Chemother%20Pharmacol&amp;title=Prevention%20of%20cisplatin-induced%20hearing%20loss%20by%20administration%20of%20a%20thiosulfate-containing%20gel%20to%20the%20middle%20ear%20in%20a%20Guinea%20pig%20model&amp;author=CE%20Berglin&amp;author=PV%20Pierre&amp;author=T%20Bramer&amp;volume=68&amp;publication_year=2011&amp;pages=1547-1556&amp;pmid=21533919&amp;doi=10.1007/s00280-011-1656-2&amp;" class="usa-link usa-link--external" data-ga-action="click_feat_suppl" target="_blank" rel="noopener noreferrer">Google Scholar</a>]</li>
<li id="b18">
<span class="label">18.</span><cite>
Andersson A, Fagerberg J, Lewensohn R, et al. 
Pharmacokinetics of cisplatin and its monohydrated complex in humans. 






J Pharm Sci. 1996;85:824–827. doi: 10.1021/js960037a.</cite> [<a href="https://doi.org/10.1021/js960037a" class="usa-link usa-link--external" data-ga-action="click_feat_suppl" target="_blank" rel="noopener noreferrer">DOI</a>] [<a href="https://pubmed.ncbi.nlm.nih.gov/8863271/" class="usa-link">PubMed</a>] [<a href="https://scholar.google.com/scholar_lookup?journal=J%20Pharm%20Sci&amp;title=Pharmacokinetics%20of%20cisplatin%20and%20its%20monohydrated%20complex%20in%20humans&amp;author=A%20Andersson&amp;author=J%20Fagerberg&amp;author=R%20Lewensohn&amp;volume=85&amp;publication_year=1996&amp;pages=824-827&amp;pmid=8863271&amp;doi=10.1021/js960037a&amp;" class="usa-link usa-link--external" data-ga-action="click_feat_suppl" target="_blank" rel="noopener noreferrer">Google Scholar</a>]</li>
<li id="b19">
<span class="label">19.</span><cite>
Rajkumar P, Mathew BS, Das S, et al. 
Cisplatin concentrations in long and short duration infusion: Implications for the optimal time of radiation delivery. 





J Clin Diagn Res. 2016;10:Xc01–xc04. doi: 10.7860/JCDR/2016/18181.8126.</cite> [<a href="https://doi.org/10.7860/JCDR/2016/18181.8126" class="usa-link usa-link--external" data-ga-action="click_feat_suppl" target="_blank" rel="noopener noreferrer">DOI</a>] [<a href="/articles/PMC5020194/" class="usa-link">PMC free article</a>] [<a href="https://pubmed.ncbi.nlm.nih.gov/27630935/" class="usa-link">PubMed</a>] [<a href="https://scholar.google.com/scholar_lookup?journal=J%20Clin%20Diagn%20Res&amp;title=Cisplatin%20concentrations%20in%20long%20and%20short%20duration%20infusion:%20Implications%20for%20the%20optimal%20time%20of%20radiation%20delivery&amp;author=P%20Rajkumar&amp;author=BS%20Mathew&amp;author=S%20Das&amp;volume=10&amp;publication_year=2016&amp;pages=Xc01-xc04&amp;pmid=27630935&amp;doi=10.7860/JCDR/2016/18181.8126&amp;" class="usa-link usa-link--external" data-ga-action="click_feat_suppl" target="_blank" rel="noopener noreferrer">Google Scholar</a>]</li>
</ul></section></section><section id="_ad93_" lang="en" class="associated-data"><h2 class="pmc_sec_title">Associated Data</h2>
<p class="font-secondary"><em>This section collects any data citations, data availability statements, or supplementary materials included in this article.</em></p>
<section id="_adda93_" lang="en" class="data-availability-statement"><h3 class="pmc_sec_title">Data Availability Statement</h3>
<p>A data sharing statement provided by the authors is available with this article at DOI <a href="https://ascopubs.org/doi/full/10.1200/JCO.24.00905" class="usa-link usa-link--external" data-ga-action="click_feat_suppl" target="_blank" rel="noopener noreferrer">https://doi.org/10.1200/JCO.24.00905</a>.</p></section></section></section><footer class="p courtesy-note font-secondary font-sm text-center"><hr class="headless">
<p>Articles from Journal of Clinical Oncology are provided here courtesy of <strong>Wolters Kluwer Health</strong></p></footer></section></article>

                      

                    </main>
                </div>
            </div>
        </div>

        



<!-- Secondary navigation placeholder -->
<div class="pmc-sidenav desktop:grid-col-4 display-flex">
    <section class="pmc-sidenav__container" aria-label="Article resources and navigation">
        <button type="button" class="usa-button pmc-sidenav__container__close usa-button--unstyled">
            <img src="/static/img/usa-icons/close.svg" role="img" alt="Close" />
        </button>
    <div class="display-none desktop:display-block">
       <section class="margin-top-4 desktop:margin-top-0">
              <h2 class="margin-top-0">ACTIONS</h2>
           <ul class="usa-list usa-list--unstyled usa-list--actions">
               
               <li>
                     <a
                             href="https://doi.org/10.1200/JCO.24.00905"
                             class="usa-button usa-button--outline width-24 font-xs display-inline-flex flex-align-center flex-justify-start padding-left-1"
                             target="_blank"
                             rel="noreferrer noopener"
                             data-ga-category="actions"
                             data-ga-action="click"
                             data-ga-label="publisher_link_desktop"
                     >
                         <svg class="usa-icon width-3 height-3" aria-hidden="true" focusable="false" role="img" hidden>
                            <use xlink:href="/static/img/sprite.svg#launch"></use>
                         </svg>
                         <span class="display-inline-flex flex-justify-center flex-1 padding-right-2">View on publisher site</span>
                     </a>
               </li>
               
               
               <li>
                    <a
                            href="pdf/jco-43-2155.pdf"
                            class="usa-button usa-button--outline width-24 display-inline-flex flex-align-center flex-justify-start padding-left-1"
                            data-ga-category="actions"
                            data-ga-action="click"
                            data-ga-label="pdf_download_desktop"
                    >
                         <svg class="usa-icon width-3 height-3" aria-hidden="true" focusable="false" role="img" hidden>
                            <use xlink:href="/static/img/sprite.svg#file_download"></use>
                        </svg>
                        <span class="display-inline-flex flex-justify-center flex-1">PDF (901.4 KB)</span>
                    </a>
               </li>
               
                
               <li>
                   <button role="button" class="usa-button width-24 citation-dialog-trigger display-inline-flex flex-align-center flex-justify-start padding-left-1"
                        aria-label="Open dialog with citation text in different styles"
                        data-ga-category="actions"
                        data-ga-action="open"
                        data-ga-label="cite_desktop"
                        data-all-citations-url="/resources/citations/12199801/"
                        data-citation-style="nlm"
                        data-download-format-link="/resources/citations/12199801/export/"
                    >
                        <svg class="usa-icon width-3 height-3" aria-hidden="true" focusable="false" role="img" hidden>
                            <use xlink:href="/static/img/sprite.svg#format_quote"></use>
                        </svg>
                       <span class="display-inline-flex flex-justify-center flex-1 button-label">Cite</span>
                    </button>
               </li>
                
               <li>

                        <button class="usa-button width-24 collections-dialog-trigger collections-button display-inline-flex flex-align-center flex-justify-start padding-left-1 collections-button-empty"
                              aria-label="Save article in MyNCBI collections."
                              data-ga-category="actions"
                              data-ga-action="click"
                              data-ga-label="collections_button_desktop"
                              data-collections-open-dialog-enabled="false"
                              data-collections-open-dialog-url="https://account.ncbi.nlm.nih.gov/?back_url=https%3A%2F%2Fpmc.ncbi.nlm.nih.gov%2Farticles%2FPMC12199801%2F%23open-collections-dialog"
                              data-in-collections="false">
                            <svg class="usa-icon width-3 height-3 usa-icon--bookmark-full" aria-hidden="true" focusable="false" role="img" hidden>
                                <use xlink:href="/static/img/action-bookmark-full.svg#icon"></use>
                            </svg>
                            <svg class="usa-icon width-3 height-3 usa-icon--bookmark-empty" aria-hidden="true" focusable="false" role="img" hidden>
                                <use xlink:href="/static/img/action-bookmark-empty.svg#icon"></use>
                            </svg>
                            <span class="display-inline-flex flex-justify-center flex-1">Collections</span>
                       </button>
               </li>
               <li class="pmc-permalink">
                    <button
                            type="button"
                            class="usa-button width-24 display-inline-flex flex-align-center flex-justify padding-left-1 shadow-none"
                            aria-label="Show article permalink"
                            aria-expanded="false"
                            aria-haspopup="true"
                            data-ga-category="actions"
                            data-ga-action="open"
                            data-ga-label="permalink_desktop"
                    >
                         <svg class="usa-icon width-3 height-3" aria-hidden="true" focusable="false" role="img" hidden>
                            <use xlink:href="/static/img/sprite.svg#share"></use>
                        </svg>
                        <span class="display-inline-flex flex-justify-center flex-1 button-label">Permalink</span>
                    </button>
                   

<div class="pmc-permalink__dropdown" hidden>
    <div class="pmc-permalink__dropdown__container">
          <h2 class="usa-modal__heading margin-top-0 margin-bottom-2 text-uppercase font-sans-xs">PERMALINK</h2>
          <div class="pmc-permalink__dropdown__content">
              <input type="text" class="usa-input" value="https://pmc.ncbi.nlm.nih.gov/articles/PMC12199801/" aria-label="Article permalink">
              <button class="usa-button display-inline-flex pmc-permalink__dropdown__copy__btn margin-right-0" title="Copy article permalink" data-ga-category="save_share" data-ga-action="link" data-ga-label="copy_link">
                  <svg class="usa-icon" aria-hidden="true" focusable="false" role="img">
                    <use xlink:href="/static/img/sprite.svg#content_copy"></use>
                  </svg>
                  <span class="margin-left-1">Copy</span>
              </button>
          </div>
    </div>
</div>
               </li>
           </ul>
       </section>
     </div>

        <section class="pmc-resources margin-top-6 desktop:margin-top-4" data-page-path="/articles/PMC12199801/">
            <h2 class="margin-top-0">RESOURCES</h2>
            
                <div class="usa-accordion usa-accordion--multiselectable" data-allow-multiple>
                    <h3 class="usa-accordion__heading">
                        <button
                        type="button"
                        class="usa-accordion__button"
                        aria-expanded="false"
                        aria-controls="resources-similar-articles"
                        data-ga-category="resources_accordion"
                        data-ga-action="open_similar_articles"
                        data-ga-label="/articles/PMC12199801/"
                        data-action-open="open_similar_articles"
                        data-action-close="close_similar_articles"
                        >
                            Similar articles
                        </button>
                    </h3>
                    <div
                            id="resources-similar-articles"
                            class="usa-accordion__content usa-prose"
                            
                                data-source-url="/resources/similar-article-links/40403227/"
                            
                    >
                        
                    </div>
                    <h3 class="usa-accordion__heading">
                        <button
                        type="button"
                        class="usa-accordion__button"
                        aria-expanded="false"
                        aria-controls="resources-cited-by-other-articles"
                        data-ga-category="resources_accordion"
                        data-ga-action="open_cited_by"
                        data-ga-label="/articles/PMC12199801/"
                        data-action-open="open_cited_by"
                        data-action-close="close_cited_by"
                        >
                             Cited by other articles
                        </button>
                    </h3>
                    <div
                            id="resources-cited-by-other-articles"
                            class="usa-accordion__content usa-prose"
                            
                                data-source-url="/resources/cited-by-links/40403227/"
                            
                    >
                          
                    </div>
                    
                        <h3 class="usa-accordion__heading">
                            <button
                            type="button"
                            class="usa-accordion__button"
                            aria-expanded="false"
                            aria-controls="resources-links-to-ncbi-databases"
                            data-ga-category="resources_accordion"
                            data-ga-action="open_NCBI_links"
                            data-ga-label="/articles/PMC12199801/"
                            data-action-open="open_NCBI_links"
                            data-action-close="close_NCBI_link"
                            >
                                 Links to NCBI Databases
                            </button>
                        </h3>
                        <div
                                id="resources-links-to-ncbi-databases"
                                class="usa-accordion__content usa-prose"
                                data-source-url="/resources/db-links/12199801/"
                        >
                        </div>
                    
                    
                </div>
            
        </section>


        <section
        class="usa-in-page-nav usa-in-page-nav--wide margin-top-6 desktop:margin-top-4"
        data-title-text="On this page"
        data-title-heading-level="h2"
        data-scroll-offset="0"
        data-root-margin="-10% 0px -80% 0px"
        data-main-content-selector="main"
        data-threshold="1"
        hidden
        ></section>
    </section>
</div>


        

<div class="overlay" role="dialog" aria-label="Citation Dialog" hidden>
    <div class="dialog citation-dialog" aria-hidden="true">
        <div class="display-inline-flex flex-align-center flex-justify width-full margin-bottom-2">
            <h2 class="usa-modal__heading margin-0">Cite</h2>
             <button type="button" class="usa-button usa-button--unstyled close-overlay text-black width-auto"  tabindex="1">
                <svg class="usa-icon width-3 height-3" aria-hidden="true" focusable="false" role="img">
                    <use xlink:href="/static/img/sprite.svg#close"></use>
                </svg>
             </button>
        </div>

        

<div class="citation-text-block">
  <div class="citation-text margin-bottom-2"></div>
  <ul class="usa-list usa-list--unstyled display-inline-flex flex-justify width-full flex-align-center">
      <li>
        <button
          class="usa-button usa-button--unstyled text-no-underline display-flex flex-align-center copy-button dialog-focus"
          data-ga-category="save_share"
          data-ga-action="cite"
          data-ga-label="copy"
          tabindex="2">
            <svg class="usa-icon width-3 height-3" aria-hidden="true" focusable="false" role="img">
                <use xlink:href="/static/img/sprite.svg#content_copy"></use>
            </svg>
            <span>Copy</span>
        </button>
      </li>
      <li>
          <a
              href="#"
              role="button"
              class="usa-button usa-button--unstyled text-no-underline display-flex flex-align-center export-button"
              data-ga-category="save_share"
              data-ga-action="cite"
              data-ga-label="download"
              title="Download a file for external citation management software"
              tabindex="3">
                <svg class="usa-icon width-3 height-3" aria-hidden="true" focusable="false" role="img">
                    <use xlink:href="/static/img/sprite.svg#file_download"></use>
                </svg>
                <span class="display-none mobile-lg:display-inline">Download .nbib</span>
                <span class="display-inline mobile-lg:display-none">.nbib</span>
            </a>
      </li>
      <li>
          

<div class="display-inline-flex flex-align-center">
  <label class="usa-label margin-top-0">Format:</label>
  <select aria-label="Format" class="usa-select citation-style-selector padding-1 margin-top-0 border-0 padding-right-4" tabindex="4" >
    
      <option data-style-url-name="ama"
              value="AMA"
              >
        AMA
      </option>
    
      <option data-style-url-name="apa"
              value="APA"
              >
        APA
      </option>
    
      <option data-style-url-name="mla"
              value="MLA"
              >
        MLA
      </option>
    
      <option data-style-url-name="nlm"
              value="NLM"
              selected="selected">
        NLM
      </option>
    
  </select>
</div>
      </li>
  </ul>
</div>
    </div>
</div>

        <div class="overlay" role="dialog" hidden>
  <div id="collections-action-dialog" class="dialog collections-dialog" aria-hidden="true">
   <div class="display-inline-flex flex-align-center flex-justify width-full margin-bottom-2">
        <h2 class="usa-modal__heading margin-0">Add to Collections</h2>
    </div>
    <div class="collections-action-panel action-panel">
      


<form id="collections-action-dialog-form"
      class="usa-form maxw-full collections-action-panel-form action-panel-content action-form action-panel-smaller-selectors"
      data-existing-collections-url="/list-existing-collections/"
      data-add-to-existing-collection-url="/add-to-existing-collection/"
      data-create-and-add-to-new-collection-url="/create-and-add-to-new-collection/"
      data-myncbi-max-collection-name-length="100"
      data-collections-root-url="https://www.ncbi.nlm.nih.gov/myncbi/collections/">

    <input type="hidden" name="csrfmiddlewaretoken" value="5CMxkneME0pLZaI7mKMGqLNCwCSeJVfZTeNnA7YQfglwlFjkQRnc3DRzOxjhPmxJ">

    <fieldset class="usa-fieldset margin-bottom-2">
        <div class="usa-radio">
            <input type="radio"
            id="collections-action-dialog-new"
            class="usa-radio__input usa-radio__input--tile collections-new  margin-top-0"
            name="collections"
            value="new"
            data-ga-category="collections_button"
            data-ga-action="click"
            data-ga-label="collections_radio_new" />
            <label class="usa-radio__label" for="collections-action-dialog-new">Create a new collection</label>
        </div>
        <div class="usa-radio">
            <input type="radio"
            id="collections-action-dialog-existing"
            class="usa-radio__input usa-radio__input--tile collections-existing"
            name="collections"
            value="existing"
            checked="true"
            data-ga-category="collections_button"
            data-ga-action="click"
            data-ga-label="collections_radio_existing" />
            <label class="usa-radio__label" for="collections-action-dialog-existing">Add to an existing collection</label>
        </div>
    </fieldset>

    <fieldset class="usa-fieldset margin-bottom-2">
        <div class="action-panel-control-wrap new-collections-controls">
           <label for="collections-action-dialog-add-to-new" class="usa-label margin-top-0">
                Name your collection
               <abbr title="required" class="usa-hint usa-hint--required text-no-underline">*</abbr>
          </label>
          <input
            type="text"
            name="add-to-new-collection"
            id="collections-action-dialog-add-to-new"
            class="usa-input collections-action-add-to-new"
            pattern="[^&quot;&amp;=&lt;&gt;/]*" title="The following characters are not allowed in the Name field: &quot;&amp;=&lt;&gt;/"
            maxlength=""
            data-ga-category="collections_button"
            data-ga-action="create_collection"
            data-ga-label="non_favorties_collection"
            required
          />
        </div>
        <div class="action-panel-control-wrap existing-collections-controls">
             <label for="collections-action-dialog-add-to-existing" class="usa-label margin-top-0">
                Choose a collection
              </label>
              <select id="collections-action-dialog-add-to-existing"
                      class="usa-select collections-action-add-to-existing"
                      data-ga-category="collections_button"
                      data-ga-action="select_collection"
                      data-ga-label="($('.collections-action-add-to-existing').val() === 'Favorites') ? 'Favorites' : 'non_favorites_collection'">
              </select>
              <div class="collections-retry-load-on-error usa-input-error-message selection-validation-message">
                Unable to load your collection due to an error<br>
                <a href="#">Please try again</a>
              </div>
        </div>
    </fieldset>

    <div class="display-inline-flex">
        <button class="usa-button margin-top-0 action-panel-submit"
            type="submit"
            data-loading-label="Adding..."
            data-pinger-ignore
            data-ga-category="collections_button"
            data-ga-action="click"
            data-ga-label="add">
          Add
        </button>
        <button class="usa-button usa-button--outline margin-top-0 action-panel-cancel"
                aria-label="Close 'Add to Collections' panel"
                ref="linksrc=close_collections_panel"
                data-ga-category="collections_button"
                data-ga-action="click"
                data-ga-label="cancel">
          Cancel
        </button>
    </div>
</form>
    </div>
  </div>
</div>

        

      </div>
    </div>
  </div>



        
    
    

<footer class="ncbi-footer ncbi-dark-background " >
    
        <div class="ncbi-footer__icon-section">
            <div class="ncbi-footer__social-header">
                Follow NCBI
            </div>

            <div class="grid-container ncbi-footer__ncbi-social-icons-container">
                
                    <a href="https://twitter.com/ncbi"
                       class="ncbi-footer__social-icon ncbi-footer__social-icon--gray"
                       target="_blank"
                       rel="noreferrer noopener">
                        <svg width="40"
                             height="40"
                             viewBox="0 0 40 40"
                             fill="none"
                             xmlns="http://www.w3.org/2000/svg"
                             focusable="false"
                             aria-hidden="true">
                            <path d="m6.067 8 10.81 13.9L6 33.2h4.2l8.4-9.1 7.068 9.1H34L22.8 18.5 31.9 8h-3.5l-7.7 8.4L14.401 8H6.067Zm3.6 1.734h3.266l16.8 21.732H26.57L9.668 9.734Z">
                            </path>
                        </svg>
                        <span class="usa-sr-only">NCBI on X (formerly known as Twitter)</span>
                    </a>
                

                
                    <a href="https://www.facebook.com/ncbi.nlm"
                       class="ncbi-footer__social-icon ncbi-footer__social-icon--gray"
                       target="_blank"
                       rel="noreferrer noopener">
                        <svg width="16"
                             height="29"
                             focusable="false"
                             aria-hidden="true"
                             viewBox="0 0 16 29"
                             fill="none"
                             xmlns="http://www.w3.org/2000/svg">
                            <path d="M3.8809 21.4002C3.8809 19.0932 3.8809 16.7876 3.8809 14.478C3.8809 14.2117 3.80103 14.1452 3.54278 14.1492C2.53372 14.1638 1.52334 14.1492 0.514288 14.1598C0.302626 14.1598 0.248047 14.0972 0.248047 13.8936C0.256034 12.4585 0.256034 11.0239 0.248047 9.58978C0.248047 9.37013 0.302626 9.30224 0.528931 9.3049C1.53798 9.31688 2.54837 9.3049 3.55742 9.31555C3.80103 9.31555 3.8809 9.26097 3.87957 9.00272C3.87158 8.00565 3.85428 7.00592 3.90753 6.00884C3.97142 4.83339 4.31487 3.73115 5.04437 2.78467C5.93095 1.63318 7.15699 1.09005 8.56141 0.967577C10.5582 0.79319 12.555 0.982221 14.5518 0.927641C14.7102 0.927641 14.7462 0.99287 14.7449 1.13664C14.7449 2.581 14.7449 4.02668 14.7449 5.47104C14.7449 5.67604 14.6517 5.68669 14.4946 5.68669C13.4523 5.68669 12.4113 5.68669 11.3703 5.68669C10.3506 5.68669 9.92057 6.10868 9.90593 7.13904C9.89661 7.7647 9.91525 8.39303 9.89794 9.01869C9.88995 9.26364 9.96583 9.31822 10.2015 9.31688C11.7204 9.30623 13.2393 9.31688 14.7595 9.3049C15.0257 9.3049 15.0723 9.3728 15.0444 9.62439C14.89 10.9849 14.7515 12.3467 14.6144 13.7085C14.5691 14.1571 14.5785 14.1585 14.1458 14.1585C12.8386 14.1585 11.5313 14.1665 10.2254 14.1518C9.95119 14.1518 9.89794 14.2317 9.89794 14.4899C9.90593 19.0799 9.89794 23.6752 9.91125 28.2612C9.91125 28.5674 9.8407 28.646 9.53186 28.6433C7.77866 28.6273 6.02414 28.6366 4.27094 28.634C3.82499 28.634 3.87158 28.6992 3.87158 28.22C3.87602 25.9472 3.87913 23.6739 3.8809 21.4002Z">
                            </path>
                        </svg>
                        <span class="usa-sr-only">NCBI on Facebook</span>
                    </a>
                

                
                    <a href="https://www.linkedin.com/company/ncbinlm"
                       class="ncbi-footer__social-icon ncbi-footer__social-icon--gray"
                       target="_blank"
                       rel="noreferrer noopener">
                        <svg width="25"
                             height="23"
                             viewBox="0 0 26 24"
                             fill="none"
                             xmlns="http://www.w3.org/2000/svg"
                             focusable="false"
                             aria-hidden="true">
                            <path d="M14.6983 9.98423C15.6302 9.24808 16.5926 8.74754 17.6762 8.51991C19.673 8.09126 21.554 8.30824 23.1262 9.7526C24.2351 10.7723 24.7529 12.1115 25.0165 13.5612C25.1486 14.3363 25.2105 15.1218 25.2015 15.9081C25.2015 18.3043 25.2015 20.6898 25.2082 23.0806C25.2082 23.3468 25.1549 23.444 24.8621 23.4414C23.1297 23.4272 21.3992 23.4272 19.6704 23.4414C19.4041 23.4414 19.3429 23.3588 19.3442 23.1019C19.3535 20.5194 19.3442 17.9368 19.3442 15.3543C19.3442 14.0005 18.3258 12.9448 17.0266 12.9488C15.7273 12.9528 14.6983 14.0071 14.6983 15.361C14.6983 17.9328 14.6917 20.5047 14.6983 23.0753C14.6983 23.3708 14.6198 23.444 14.3296 23.4427C12.6185 23.4294 10.9079 23.4294 9.19779 23.4427C8.93155 23.4427 8.86099 23.3735 8.86232 23.1086C8.8783 19.7619 8.88628 16.4144 8.88628 13.066C8.88628 11.5688 8.87874 10.0708 8.86365 8.57182C8.86365 8.3575 8.90758 8.27896 9.14054 8.28029C10.9048 8.29094 12.6687 8.29094 14.4321 8.28029C14.6464 8.28029 14.6983 8.34818 14.6983 8.54653C14.6903 9.00047 14.6983 9.45441 14.6983 9.98423Z">
                            </path>
                            <path d="M6.55316 15.8443C6.55316 18.2564 6.55316 20.6699 6.55316 23.082C6.55316 23.3629 6.48127 23.4388 6.19906 23.4374C4.47737 23.4241 2.75568 23.4241 1.03399 23.4374C0.767751 23.4374 0.69986 23.3629 0.701191 23.1006C0.709178 18.2648 0.709178 13.4281 0.701191 8.59053C0.701191 8.34026 0.765089 8.27237 1.01669 8.2737C2.74991 8.28435 4.48048 8.28435 6.20838 8.2737C6.47462 8.2737 6.5465 8.33627 6.54517 8.6065C6.54783 11.0186 6.55316 13.4308 6.55316 15.8443Z">
                            </path>
                            <path d="M3.65878 0.243898C5.36804 0.243898 6.58743 1.45529 6.58743 3.1406C6.58743 4.75801 5.32145 5.95742 3.60819 5.96807C3.22177 5.97614 2.83768 5.90639 2.47877 5.76299C2.11985 5.61959 1.79344 5.40546 1.51897 5.13334C1.24449 4.86123 1.02755 4.53668 0.881058 4.17902C0.734563 3.82136 0.661505 3.43788 0.666231 3.05141C0.67555 1.42601 1.9362 0.242566 3.65878 0.243898Z">
                            </path>
                        </svg>
                        <span class="usa-sr-only">NCBI on LinkedIn</span>
                    </a>
                

                
                    <a href="https://github.com/ncbi"
                       class="ncbi-footer__social-icon ncbi-footer__social-icon--gray"
                       target="_blank"
                       rel="noreferrer noopener">
                        <svg width="28"
                             height="27"
                             viewBox="0 0 28 28"
                             fill="none"
                             xmlns="http://www.w3.org/2000/svg"
                             focusable="false"
                             aria-hidden="true">
                            <path d="M16.7228 20.6334C17.5057 20.5527 18.2786 20.3944 19.0301 20.1608C21.3108 19.4193 22.5822 17.8259 22.963 15.4909C23.1228 14.5112 23.1814 13.5287 22.9883 12.5437C22.8106 11.6423 22.4013 10.8028 21.8007 10.1076C21.7526 10.0605 21.7197 10 21.7064 9.934C21.6931 9.86799 21.7 9.79952 21.7262 9.73748C22.0856 8.6206 21.9711 7.51969 21.601 6.42677C21.582 6.3497 21.5345 6.2827 21.468 6.23923C21.4016 6.19577 21.3211 6.17906 21.2429 6.19248C20.7329 6.21649 20.2313 6.33051 19.7611 6.52928C19.1103 6.7908 18.4899 7.12198 17.9104 7.51703C17.84 7.56996 17.7581 7.60551 17.6713 7.62078C17.5846 7.63605 17.4954 7.6306 17.4112 7.60489C15.2596 7.05882 13.0054 7.06203 10.8554 7.61421C10.7806 7.63586 10.7018 7.63967 10.6253 7.62534C10.5487 7.611 10.4766 7.57892 10.4148 7.53167C9.64788 7.03247 8.85171 6.58918 7.96368 6.33359C7.65781 6.24338 7.34123 6.19458 7.02239 6.18849C6.94879 6.17986 6.87462 6.19893 6.81432 6.242C6.75402 6.28507 6.71191 6.34904 6.69621 6.42145C6.32342 7.51437 6.2209 8.61527 6.56307 9.73348C6.59635 9.84264 6.64694 9.93316 6.54177 10.0516C5.47666 11.2604 5.09988 12.6834 5.19574 14.2676C5.2663 15.4244 5.46201 16.5466 6.01454 17.5769C6.84399 19.1171 8.21664 19.9119 9.85158 20.3352C10.3938 20.4706 10.9444 20.5698 11.4998 20.632C11.5384 20.7492 11.4506 20.7798 11.408 20.8291C11.1734 21.1179 10.9894 21.4441 10.8634 21.7942C10.7622 22.0458 10.8315 22.4039 10.6065 22.5516C10.263 22.7766 9.83827 22.8485 9.42421 22.8871C8.17936 23.0056 7.26471 22.4877 6.6283 21.4348C6.25552 20.8184 5.76956 20.3325 5.08523 20.0663C4.76981 19.9325 4.42139 19.8967 4.08537 19.9638C3.7898 20.029 3.73788 20.1901 3.93891 20.4111C4.03639 20.5234 4.14989 20.6207 4.27575 20.6999C4.9796 21.1318 5.51717 21.7884 5.80152 22.5636C6.37002 23.9973 7.48039 24.5697 8.93825 24.6323C9.43741 24.6575 9.93768 24.615 10.4254 24.5058C10.5892 24.4672 10.6531 24.4872 10.6517 24.6762C10.6451 25.4936 10.6637 26.3123 10.6517 27.131C10.6517 27.6635 10.1684 27.9297 9.58663 27.7393C8.17396 27.2671 6.84977 26.5631 5.66838 25.656C2.59555 23.2891 0.720966 20.1861 0.217704 16.3376C-0.357453 11.9127 0.911353 8.00824 3.98551 4.73881C6.11909 2.42656 8.99932 0.939975 12.1203 0.540191C16.5351 -0.0601815 20.4347 1.14323 23.7232 4.16373C26.2449 6.47869 27.724 9.37672 28.1048 12.7726C28.5828 17.0325 27.3686 20.7945 24.4768 23.9827C22.9762 25.6323 21.0956 26.8908 18.9982 27.6488C18.8783 27.6927 18.7585 27.738 18.636 27.7726C18.0356 27.9404 17.6189 27.6395 17.6189 27.0098C17.6189 25.7452 17.6308 24.4806 17.6295 23.2159C17.6329 22.9506 17.6128 22.6856 17.5696 22.4238C17.4325 21.6664 17.3419 21.484 16.7228 20.6334Z">
                            </path>
                        </svg>
                        <span class="usa-sr-only">NCBI on GitHub</span>
                    </a>
                

                
                    <a href="https://ncbiinsights.ncbi.nlm.nih.gov/"
                       class="ncbi-footer__social-icon ncbi-footer__social-icon--gray"
                       target="_blank"
                       rel="noreferrer noopener">
                        <svg width="26"
                             height="26"
                             viewBox="0 0 27 27"
                             fill="none"
                             xmlns="http://www.w3.org/2000/svg"
                             focusable="false"
                             aria-hidden="true">
                            <path d="M23.7778 26.4574C23.1354 26.3913 22.0856 26.8024 21.636 26.3087C21.212 25.8444 21.4359 24.8111 21.324 24.0347C19.9933 14.8323 14.8727 8.80132 6.09057 5.85008C4.37689 5.28406 2.58381 4.99533 0.779072 4.99481C0.202773 4.99481 -0.0229751 4.83146 0.00455514 4.21479C0.0660406 3.08627 0.0660406 1.95525 0.00455514 0.826734C-0.0413285 0.0815827 0.259669 -0.0193618 0.896534 0.00266238C6.96236 0.222904 12.3693 2.24179 16.9889 6.16209C22.9794 11.2478 26.1271 17.7688 26.4372 25.648C26.4629 26.294 26.3179 26.5271 25.6609 26.4684C25.0827 26.417 24.4991 26.4574 23.7778 26.4574Z">
                            </path>
                            <path d="M14.8265 26.441C14.0924 26.441 13.2371 26.6795 12.6626 26.3786C12.0092 26.0372 12.3781 25.0644 12.246 24.378C11.1154 18.5324 6.6849 14.5497 0.74755 14.1001C0.217135 14.0615 -0.0104482 13.9422 0.0134113 13.3659C0.0519536 12.1454 0.0482829 10.9213 0.0134113 9.69524C-0.00127145 9.14464 0.196946 9.03268 0.703502 9.04736C9.21217 9.27128 16.5994 16.2511 17.2804 24.7231C17.418 26.4446 17.418 26.4446 15.6579 26.4446H14.832L14.8265 26.441Z">
                            </path>
                            <path d="M3.58928 26.4555C2.64447 26.4618 1.73584 26.0925 1.06329 25.4289C0.39073 24.7653 0.00933763 23.8617 0.0030097 22.9169C-0.00331824 21.9721 0.365937 21.0635 1.02954 20.3909C1.69315 19.7184 2.59675 19.337 3.54156 19.3306C4.48637 19.3243 5.39499 19.6936 6.06755 20.3572C6.7401 21.0208 7.1215 21.9244 7.12782 22.8692C7.13415 23.814 6.7649 24.7226 6.10129 25.3952C5.43768 26.0677 4.53409 26.4491 3.58928 26.4555Z">
                            </path>
                        </svg>
                        <span class="usa-sr-only">NCBI RSS feed</span>
                    </a>
                
            </div>
        </div>
    

    <div data-testid="gridContainer"
         class="grid-container ncbi-footer__container">
        <div class="grid-row ncbi-footer__main-content-container"
             data-testid="grid">
            
                <div class="ncbi-footer__column">
                    
                        <p class="ncbi-footer__circled-icons-heading">
                            Connect with NLM
                        </p>
                    

                    <div class="ncbi-footer__circled-icons-list">
                        
                            <a href=https://twitter.com/nlm_nih class="ncbi-footer__social-icon ncbi-footer__social-icon--circled" target="_blank" rel="noreferrer noopener">
                                <svg width="32"
                                     height="32"
                                     viewBox="0 0 40 40"
                                     fill="none"
                                     xmlns="http://www.w3.org/2000/svg"
                                     focusable="false"
                                     aria-hidden="true">
                                    <path d="m6.067 8 10.81 13.9L6 33.2h4.2l8.4-9.1 7.068 9.1H34L22.8 18.5 31.9 8h-3.5l-7.7 8.4L14.401 8H6.067Zm3.6 1.734h3.266l16.8 21.732H26.57L9.668 9.734Z">
                                    </path>
                                </svg>
                                <span class="usa-sr-only">NLM on X (formerly known as Twitter)</span>
                            </a>
                        

                        
                            <a href=https://www.facebook.com/nationallibraryofmedicine class="ncbi-footer__social-icon ncbi-footer__social-icon--circled" target="_blank" rel="noreferrer noopener">
                                <svg width="13"
                                     height="24"
                                     viewBox="0 0 13 24"
                                     fill="none"
                                     xmlns="http://www.w3.org/2000/svg"
                                     focusable="false"
                                     aria-hidden="true">
                                    <path d="M4.11371 23.1369C4.11371 23.082 4.11371 23.0294 4.11371 22.9745V12.9411H0.817305C0.6709 12.9411 0.670898 12.9411 0.670898 12.8016C0.670898 11.564 0.670898 10.3287 0.670898 9.09341C0.670898 8.97903 0.705213 8.95158 0.815017 8.95158C1.8673 8.95158 2.91959 8.95158 3.97417 8.95158H4.12057V8.83263C4.12057 7.8055 4.12057 6.7738 4.12057 5.74897C4.1264 4.92595 4.31387 4.11437 4.66959 3.37217C5.12916 2.38246 5.94651 1.60353 6.95717 1.1921C7.64827 0.905008 8.3913 0.764035 9.13953 0.778051C10.0019 0.791777 10.8644 0.830666 11.7268 0.860404C11.8869 0.860404 12.047 0.894717 12.2072 0.90158C12.2964 0.90158 12.3261 0.940469 12.3261 1.02968C12.3261 1.5421 12.3261 2.05452 12.3261 2.56465C12.3261 3.16857 12.3261 3.7725 12.3261 4.37642C12.3261 4.48165 12.2964 4.51367 12.1912 4.51138C11.5369 4.51138 10.8804 4.51138 10.2261 4.51138C9.92772 4.51814 9.63058 4.5526 9.33855 4.61433C9.08125 4.6617 8.84537 4.78881 8.66431 4.97766C8.48326 5.16652 8.3662 5.40755 8.32972 5.66661C8.28476 5.89271 8.26027 6.1224 8.25652 6.35289C8.25652 7.19014 8.25652 8.02969 8.25652 8.86923C8.25652 8.89439 8.25652 8.91955 8.25652 8.95615H12.0219C12.1797 8.95615 12.182 8.95616 12.1614 9.10714C12.0768 9.76596 11.9876 10.4248 11.9029 11.0813C11.8312 11.6319 11.7626 12.1824 11.697 12.733C11.6719 12.9434 11.6787 12.9434 11.4683 12.9434H8.26338V22.899C8.26338 22.979 8.26338 23.0591 8.26338 23.1392L4.11371 23.1369Z">
                                    </path>
                                </svg>
                                <span class="usa-sr-only">NLM on Facebook</span>
                            </a>
                        

                        
                            <a href=https://www.youtube.com/user/NLMNIH class="ncbi-footer__social-icon ncbi-footer__social-icon--circled" target="_blank" rel="noreferrer noopener">
                                <svg width="21"
                                     height="15"
                                     viewBox="0 0 21 15"
                                     fill="none"
                                     xmlns="http://www.w3.org/2000/svg"
                                     focusable="false"
                                     aria-hidden="true">
                                    <path d="M19.2561 1.47914C18.9016 1.15888 18.5699 0.957569 17.2271 0.834039C15.5503 0.678484 13.2787 0.655608 11.563 0.65332H9.43556C7.71987 0.65332 5.4483 0.678484 3.77151 0.834039C2.43098 0.957569 2.097 1.15888 1.74242 1.47914C0.813665 2.32097 0.619221 4.62685 0.598633 6.89384C0.598633 7.31781 0.598633 7.74101 0.598633 8.16345C0.626084 10.4121 0.827391 12.686 1.74242 13.521C2.097 13.8412 2.4287 14.0425 3.77151 14.1661C5.4483 14.3216 7.71987 14.3445 9.43556 14.3468H11.563C13.2787 14.3468 15.5503 14.3216 17.2271 14.1661C18.5676 14.0425 18.9016 13.8412 19.2561 13.521C20.1712 12.6929 20.3725 10.451 20.3999 8.22064C20.3999 7.74025 20.3999 7.25986 20.3999 6.77946C20.3725 4.54907 20.1689 2.30724 19.2561 1.47914ZM8.55942 10.5311V4.65201L13.5601 7.50005L8.55942 10.5311Z"
                                          fill="white" />
                                </svg>
                                <span class="usa-sr-only">NLM on YouTube</span>
                            </a>
                        
                    </div>
                </div>
            

            
                <address class="ncbi-footer__address ncbi-footer__column">
                    
        <p>
            <a class="usa-link usa-link--external"
            href="https://www.google.com/maps/place/8600+Rockville+Pike,+Bethesda,+MD+20894/%4038.9959508,
            -77.101021,17z/data%3D!3m1!4b1!4m5!3m4!1s0x89b7c95e25765ddb%3A0x19156f88b27635b8!8m2!3d38.9959508!
            4d-77.0988323"
            rel="noopener noreferrer" target="_blank">National Library of Medicine
            <br/> 8600 Rockville Pike<br/> Bethesda, MD 20894</a>
        </p>
    
                </address>
            

            
                <ul class="usa-list usa-list--unstyled ncbi-footer__vertical-list ncbi-footer__column">
                    
                        <li class="ncbi-footer__vertical-list-item">
                            









    <a href="https://www.nlm.nih.gov/web_policies.html" class="usa-link  usa-link--alt ncbi-footer__link"  >
        

        
            Web Policies
        

        
    </a>


                        </li>
                    
                        <li class="ncbi-footer__vertical-list-item">
                            









    <a href="https://www.nih.gov/institutes-nih/nih-office-director/office-communications-public-liaison/freedom-information-act-office" class="usa-link  usa-link--alt ncbi-footer__link"  >
        

        
            FOIA
        

        
    </a>


                        </li>
                    
                        <li class="ncbi-footer__vertical-list-item">
                            









    <a href="https://www.hhs.gov/vulnerability-disclosure-policy/index.html" class="usa-link usa-link--external usa-link--alt ncbi-footer__link" rel="noreferrer noopener" target='_blank' >
        

        
            HHS Vulnerability Disclosure
        

        
    </a>


                        </li>
                    
                </ul>
            

            
                <ul class="usa-list usa-list--unstyled ncbi-footer__vertical-list ncbi-footer__column">
                    
                        <li class="ncbi-footer__vertical-list-item">
                            









    <a href="https://support.nlm.nih.gov/" class="usa-link  usa-link--alt ncbi-footer__link"  >
        

        
            Help
        

        
    </a>


                        </li>
                    
                        <li class="ncbi-footer__vertical-list-item">
                            









    <a href="https://www.nlm.nih.gov/accessibility.html" class="usa-link  usa-link--alt ncbi-footer__link"  >
        

        
            Accessibility
        

        
    </a>


                        </li>
                    
                        <li class="ncbi-footer__vertical-list-item">
                            









    <a href="https://www.nlm.nih.gov/careers/careers.html" class="usa-link  usa-link--alt ncbi-footer__link"  >
        

        
            Careers
        

        
    </a>


                        </li>
                    
                </ul>
            
        </div>

        
            <div class="grid-row grid-col-12" data-testid="grid">
                <ul class="ncbi-footer__bottom-links-list">
                    
                        <li class="ncbi-footer__bottom-list-item">
                            









    <a href="https://www.nlm.nih.gov/" class="usa-link  usa-link--alt ncbi-footer__link"  >
        

        
            NLM
        

        
    </a>


                        </li>
                    
                        <li class="ncbi-footer__bottom-list-item">
                            









    <a href="https://www.nih.gov/" class="usa-link  usa-link--alt ncbi-footer__link"  >
        

        
            NIH
        

        
    </a>


                        </li>
                    
                        <li class="ncbi-footer__bottom-list-item">
                            









    <a href="https://www.hhs.gov/" class="usa-link usa-link--external usa-link--alt ncbi-footer__link" rel="noreferrer noopener" target='_blank' >
        

        
            HHS
        

        
    </a>


                        </li>
                    
                        <li class="ncbi-footer__bottom-list-item">
                            









    <a href="https://www.usa.gov/" class="usa-link usa-link--external usa-link--alt ncbi-footer__link" rel="noreferrer noopener" target='_blank' >
        

        
            USA.gov
        

        
    </a>


                        </li>
                    
                </ul>
            </div>
        
    </div>
</footer>

    


        
        
    
  <script  type="text/javascript" src="https://cdn.ncbi.nlm.nih.gov/core/pinger/pinger.js"> </script>


    
        

<button class="back-to-top" data-ga-category="pagination" data-ga-action="back_to_top">
    <label>Back to Top</label>
    <svg class="usa-icon order-0" aria-hidden="true" focusable="false" role="img">
        <use xlink:href="/static/img/sprite.svg#arrow_upward"></use>
    </svg>
</button>
    


        
    
    
    
        
    <script type="application/javascript">
    window.ncbi = window.ncbi || {};
    window.ncbi.pmc = window.ncbi.pmc || {};
    window.ncbi.pmc.options = {
        logLevel: 'INFO',
        
        staticEndpoint: '/static/',
        
        citeCookieName: 'pmc-cf',
    };
</script>
    <script type="module" crossorigin="" src="/static/assets/base-B7-tgZZA.js"></script>
    
    <script type="text/javascript" src="https://cdn.ncbi.nlm.nih.gov/core/jquery/jquery-3.6.0.min.js">&#xA0;</script>
    <script type="text/javascript">
        jQuery.getScript("https://cdn.ncbi.nlm.nih.gov/core/alerts/alerts.js", function () {
            galert(['div.nav_and_browser', 'div.header', '#universal_header', '.usa-banner', 'body > *:nth-child(1)'])
        });
    </script>


    <script type="text/javascript">var exports = {};</script>
     <script src="/static/CACHE/js/output.13b077bc3ffd.js"></script>

    <script type="module" crossorigin="" src="/static/assets/article-BLbQGH8u.js"></script>
    
    

    </body>
</html>
